Everspin (MRAM) 10-K 15 Mar 19 2018 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Mar. 06, 2019	Jun. 29, 2018
Document And Entity Information
Document Type	10-K
Amendment Flag	false
Document Period End Date	Dec. 31, 2018
Document Fiscal Year Focus	2018
Document Fiscal Period Focus	FY
Trading Symbol	mram
Entity Registrant Name	EVERSPIN TECHNOLOGIES INC
Entity Central Index Key	0001438423
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Accelerated Filer
Entity Public Float			$ 116.6
Entity Common Stock, Shares Outstanding		17,095,552
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	true
Entity Shell Company	false

Balance Sheets

Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Current assets:
Cash and cash equivalents	$ 23,379	$ 12,950
Accounts receivable, net	7,522	4,041
Inventory	9,097	9,837
Prepaid expenses and other current assets	688	590
Total current assets	40,686	27,418
Property and equipment, net	4,286	3,946
Other assets	73	73
Total assets	45,045	31,437
Current liabilities:
Accounts payable	2,637	2,920
Accrued liabilities	5,001	3,748
Deferred income on shipments to distributors		1,720
Current portion of long-term debt	5,977	3,987
Total current liabilities	13,615	12,375
Long-term debt, net of current portion	6,509	8,178
Total liabilities	20,124	20,553
Commitments and contingencies
Stockholders’ equity:
Preferred stock, $0.0001 par value per share; 5,000,000 shares authorized; no shares issued and outstanding as of December 31, 2018 and December 31, 2017
Common stock, $0.0001 par value per share; 100,000,000 shares authorized; 17,095,456 and 12,817,201 shares issued and outstanding as of December 31, 2018 and December 31, 2017	2	1
Additional paid-in capital	158,912	128,422
Accumulated deficit	(133,993)	(117,539)
Total stockholders’ equity	24,921	10,884
Total liabilities and stockholders’ equity	$ 45,045	$ 31,437

Balance Sheets (Parenthetical)

Balance Sheets (Parenthetical) - $ / shares	Dec. 31, 2018	Dec. 31, 2017
Balance Sheets
Preferred Stock, Par Value	$ 0.0001	$ 0.0001
Preferred Stock, Shares Authorized	5,000,000	5,000,000
Preferred Stock, Shares Issued	0	0
Preferred Stock, Shares Outstanding	0	0
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	17,095,456	12,817,201
Common stock, shares outstanding	17,095,456	12,817,201

Statements of Operations and Co

Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Total revenue	$ 49,417	$ 35,936
Cost of sales	24,083	14,451
Gross profit	25,334	21,485
Operating expenses:
Research and development	23,637	25,437
General and administrative	12,551	11,516
Sales and marketing	6,467	4,740
Total operating expenses	42,655	41,693
Loss from operations	(17,321)	(20,208)
Interest expense	(890)	(764)
Other income, net	457	118
Loss on extinguishment of debt		(246)
Net loss and comprehensive loss	$ (17,754)	$ (21,100)
Net loss per common share, basic and diluted	$ (1.08)	$ (1.69)
Weighted-average shares used to compute net loss per common share, basic and diluted	16,372,638	12,484,984
Product sales
Total revenue	$ 39,514	$ 30,838
Licensing, royalty and other revenue
Total revenue	$ 9,903	$ 5,098

Statements of Stockholders_ Equ

Statements of Stockholders’ Equity - USD ($) $ in Thousands	Common Stock [Member]	Additional Paid-In Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2016	$ 1	$ 123,309	$ (96,439)	$ 26,871
Balance (in shares) at Dec. 31, 2016	12,498,128
Increase (Decrease) in Stockholders' Equity
Issuance of common stock upon exercise of stock options		1,337		1,337
Issuance of common stock upon exercise of stock options (in shares)	281,483
Issuance of common stock under Employee Stock Purchase Plan		256		256
Issuance of common stock under Employee Stock Purchase Plan (in shares)	37,590
Compensation expense related to vesting of common stock issued to GLOBALFOUNDRIES		1,472		1,472
Stock-based compensation expense		2,048		2,048
Net loss			(21,100)	(21,100)
Balance at Dec. 31, 2017	$ 1	128,422	(117,539)	10,884
Balance (in shares) at Dec. 31, 2017	12,817,201
Increase (Decrease) in Stockholders' Equity
Adjustment to opening balance for adoption of new accounting standard			1,300	1,300
Issuance of common stock in secondary offering, net of issuance costs	$ 1	24,523		24,524
Issuance of common stock in secondary offering, net of issuance costs (in shares)	3,772,447
Issuance of common stock under stock incentive plans		2,503		$ 2,503
Issuance of common stock under stock incentive plans (in shares)	505,808
Issuance of common stock upon exercise of stock options (in shares)				448,411
Issuance of warrant		43		$ 43
Compensation expense related to vesting of common stock issued to GLOBALFOUNDRIES		753		753
Stock-based compensation expense		2,668		2,668
Net loss			(17,754)	(17,754)
Balance at Dec. 31, 2018	$ 2	$ 158,912	$ (133,993)	$ 24,921
Balance (in shares) at Dec. 31, 2018	17,095,456

Statement of Cash Flows

Statement of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Cash flows from operating activities
Net loss	$ (17,754)	$ (21,100)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	1,450	1,191
Loss on disposal of property and equipment	19
Stock-based compensation	2,668	2,048
Non-cash loss on extinguishment of debt		185
Non-cash interest expense	375	297
Compensation expense related to vesting of common stock to GLOBALFOUNDRIES	753	1,472
Changes in operating assets and liabilities:
Accounts receivable	(3,816)	(385)
Inventory	694	(3,871)
Prepaid expenses and other current assets	(98)	460
Other assets		(23)
Accounts payable	(178)	809
Accrued liabilities	1,253	136
Deferred income on shipments to distributors		(107)
Shipping term reversal	(39)
Net cash used in operating activities	(14,673)	(18,888)
Cash flows from investing activities
Purchases of property and equipment	(1,914)	(3,070)
Net cash used in investing activities	(1,914)	(3,070)
Cash flows from financing activities
Proceeds from the issuance of common stock, net of offering costs	24,524
Proceeds from debt	1,000	12,000
Payments on debt	(1,000)	(8,356)
Payments of debt issuance costs		(49)
Payments on capital lease obligation	(11)	(7)
Proceeds from exercise of stock options and purchase of shares in employee stock purchase plan	2,503	1,593
Net cash provided by financing activities	27,016	5,181
Net increase (decrease) in cash and cash equivalents	10,429	(16,777)
Cash and cash equivalents at beginning of period	12,950	29,727
Cash and cash equivalents at end of period	23,379	12,950
Supplementary cash flow information:
Interest paid	504	467
Non-cash investing and financing activities:
Purchases of property and equipment in accounts payable	11	116
Purchases of property and equipment under capital lease obligations		$ 31
Issuance of warrant in lieu of financing costs	$ 43

Organization and Operations

Organization and Operations	12 Months Ended
	Dec. 31, 2018
Organization and Operations
Organization and Operations	1. Organization and Operations Everspin Technologies, Inc. (the Company) was incorporated in Delaware on May 16, 2008. The Company’s magnetoresistive random access memory (MRAM) solutions offer the persistence of non-volatile memory with the speed and endurance of random access memory (RAM) and enable the protection of mission critical data particularly in the event of power interruption or failure. The Company’s MRAM solutions allow its customers in the industrial, automotive and transportation, and enterprise storage markets to design high performance, power efficient and reliable systems without the need for bulky batteries or capacitors. Ability to continue as a going concern The Company believes that its existing cash and cash equivalents as of December 31, 2018 will be sufficient to meet its anticipated cash requirements for at least the next 12 months from the financial statement issuance date. The Company’s future capital requirements will depend on many factors, including its growth rate, the timing and extent of its spending to support research and development activities, the timing and cost of establishing additional sales and marketing capabilities, and the introduction of new products. The Company may be required at some point in the future to seek additional equity or debt financing, to sustain operations beyond that point, and such additional financing may not be available on acceptable terms or at all. If the Company is unable to raise additional capital or generate sufficient cash from operations to adequately fund its operations, it will need to curtail planned activities to reduce costs. Doing so will likely harm its ability to execute on its business plan.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2018
Summary of Significant Accounting Policies
Summary of Significant Accounting Policies	2. Summary of Significant Accounting Policies Use of Estimates The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP). The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. On an ongoing basis, management evaluates its estimates, including those related to revenue recognition, fair value of assets and liabilities, inventory, product warranty reserves, income taxes, and stock-based compensation. The Company believes its estimates and assumptions are reasonable; however, actual results may differ from the Company’s estimates. Segments The Company’s chief operating decision maker is its Chief Executive Officer who reviews financial information presented on a consolidated basis for purposes of allocating resources and evaluating financial performance for the entire Company. As a result, the Company has single operating and reportable segment.. Cash and Cash Equivalents The Company considers all highly liquid, short-term investments with maturity dates of 90 days or less at the date of purchase to be cash equivalents. The Company’s cash equivalents consist solely of money market funds. Accounts Receivable Accounts receivable are recorded at the invoiced amount and do not bear interest. The Company generally does not require collateral or other security in support of accounts receivable. Allowances are provided for individual accounts receivable when the Company becomes aware of a customer’s inability to meet its financial obligations, such as in the case of bankruptcy, deterioration in the customer’s operating results or change in financial position. If circumstances related to customers change, estimates of the recoverability of receivables would be further adjusted. The Company also considers a number of factors in evaluating the sufficiency of its allowance for doubtful accounts, including the length of time receivables are past due, significant one-time events, creditworthiness of customers and historical experience. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. At December 31, 2018 and 2017, there was no allowance for doubtful accounts. The Company establishes an allowance for product returns. The Company analyzes historical returns, current economic trends and changes in customer demand and acceptance of products when evaluating the adequacy of sales returns. As the returns are processed as credits on future purchases, the allowance is recorded against the balance of trade accounts receivable. In addition, the Company establishes an allowance for estimated price concessions related to its distributer agreements. The Company estimates credits to distributors based on the historical rate of credits provided to distributors relative to sales. The allowance for product returns and the allowance for price concessions were $144,000 and $569,000 at December 31, 2018, respectively, and $147,000 and $0 at December 31, 2017, respectively. Accounts receivable, net consisted of the following (in thousands): December 31, 2018 2017 Trade accounts receivable $ 7,297 $ 4,188 Unbilled accounts receivable 938 — Allowance for accounts receivable (713) (147) Accounts receivable, net $ 7,522 $ 4,041 Concentration of Credit Risk Financial instruments that potentially expose the Company to a concentration of credit risk consist principally of cash and cash equivalents that are held by a financial institution in the United States and accounts receivable. Amounts on deposit with a financial institution may at times exceed federally insured limits. The Company maintains its cash accounts with high credit quality financial institutions and accordingly, minimal credit risk exists with respect to the financial institutions. Significant customers are those which represent more than 10% of the Company’s total revenue or net accounts receivable balance at each respective balance sheet date. For the purposes of this disclosure, the Company defines “customer” as the entity that is purchasing the products or licenses directly from the Company, which includes the distributors of the Company’s products in addition to end customers that the Company sells to directly. For each significant customer, revenue as a percentage of total revenue and accounts receivable as a percentage of total accounts receivable, net are as follows: Revenue Accounts Receivable, net Year Ended As of December 31, December 31, Customers 2018 2017 2018 2017 Customer A 13 % 16 % * * Customer B 11 % * * * Customer C 10 % * * 11 % Customer D * 15 % * * Customer E * * 23 % * Customer F * * 21 % * Customer G * * 11 % 15 % Customer H * * 11 % * Customer I * * * 10 % * Inventory Inventory is valued at the lower of cost, using the first-in, first-out or specific identification method, or market. The carrying value of inventory is adjusted for excess and obsolete inventory based on inventory age, shipment history and the forecast of demand over a specific future period. At the point of loss recognition, a new lower cost basis for that inventory is established and subsequent changes in facts and circumstances do not result in the restoration or increase in that new cost basis. Fair Value of Financial Instruments Fair value is defined as an exit price, representing the amount that would be received to sell an asset, or paid to transfer a liability, in an orderly transaction between market participants. The framework for measuring fair value provides a three-tier hierarchy prioritizing inputs to valuation techniques used in measuring fair value as follows: Level 1 — Observable inputs such as quoted prices for identical assets or liabilities in active markets; Level 2 — Inputs, other than quoted prices for identical assets or liabilities in active markets, which are observable either directly or indirectly; and Level 3 — Unobservable inputs in which there is little or no market data requiring the reporting entity to develop its own assumptions. The carrying value of accounts receivable, accounts payable, and other accruals readily convertible into cash approximate fair value because of the short-term nature of the instruments. As of December 31, 2018, based on Level 2 inputs and the borrowing rates available to the Company for loans with similar terms and consideration of the Company’s credit risk, the carrying value of the Company’s variable interest rate debt, excluding unamortized debt issuance costs, approximates fair value. The Company’s financial instruments consist of Level 1 assets. Where quoted prices are available in an active market, securities are classified as Level 1. Level 1 assets consist of highly liquid money market funds that are included in cash equivalents. The following tables sets forth the fair value of the Company’s financial assets measured at fair value on a recurring basis (in thousands): December 31, 2018 Level 1 Level 2 Level 3 Total Assets: Money market funds $ 23,478 $ — $ — $ 23,478 Total assets measured at fair value $ 23,478 $ — $ — $ 23,478 December 31, 2017 Level 1 Level 2 Level 3 Total Assets: Money market funds $ 13,369 $ — $ — $ 13,369 Total assets measured at fair value $ 13,369 $ — $ — $ 13,369 Property and Equipment Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation begins at the time the asset is placed in service. Maintenance and repairs are charged to operations as incurred. Depreciation is computed using the straight-line method over the following estimated useful lives of the assets: Useful Lives Computer and network equipment 2 years Manufacturing equipment 2 – 7 years Furniture and fixtures 7 years Software 3 years Leasehold improvements are amortized over the shorter of the lease term or useful life. Upon sale or retirement of assets, the cost and related accumulated depreciation are removed from the balance sheet and the resulting gain or loss is reflected in operations. Amortization expense of assets acquired through capital leases is included in the statements of operations and comprehensive loss. Impairment of Long-lived Assets The Company evaluates its long-lived assets, including property and equipment, for impairment whenever events or changes in circumstances indicate that the carrying value of these assets may not be recoverable. Recoverability of these assets is measured by comparison of the carrying amount of each asset to the future undiscounted cash flows the asset is expected to generate over its remaining life. If the asset is considered to be impaired, the amount of any impairment is measured as the difference between the carrying value and the fair value of the impaired asset. There have been no impairments of the Company’s long-lived assets during any of the periods presented. Leases The Company leases office, lab, and manufacturing space in various locations. Rent expense under operating leases is recognized on a straight-line basis over the lease term taking into consideration rent abatements, scheduled rent increases and any lease incentives. Debt Issuance Costs The Company defers and amortizes issuance costs, underwriting fees, end of term payments, and related expenses incurred in connection with the issuance of debt instruments using the effective interest method over the terms of the respective instruments. Debt issuance costs are reflected as a direct reduction of the carrying amount of the related debt liability. Revenue Recognition The Company recognizes revenue when a customer obtains control of the promised products or services, in an amount that reflects the consideration the Company expects to receive in exchange for those products or services. Revenue is recognized net of allowances for returns and price concessions, and any taxes collected from customers, which are subsequently remitted to governmental authorities. Nature of Products and Services The Company’s revenue is derived from the sale of MRAM-based products in discrete unit form, licenses of and royalties on its MRAM and magnetic sensor technology, the sale of backend foundry services and design services to third parties. Sales of products in discrete unit form are recognized at a point in time, revenue related to licensing agreements is recognized when the Company has delivered control of the technology, revenue related to royalty agreements is recognized in the period in which sales generated from products sold using the Company’s technology occurs, sales of backend foundry services are recognized over time, and design services to third parties are recognized either at a point in time or over time, depending on the nature of the services. Product Revenue For products sold in their discrete form, the Company either sells its products directly to original equipment manufacturers (OEMs), original design manufacturers (ODMs) and contract manufacturers (CMs), or through a network of distributors, who in turn sell to those customers. For sales directly to OEMs, ODMs and CMs, revenue is recognized when the OEM, ODM or CM obtains control of the product, which occurs at a point in time, generally upon shipment to the customer. The Company sells the majority of its products to its distributors at a uniform list price. However, distributors may resell the Company’s products to end customers at a very broad range of individually negotiated price points. Distributors are provided with price concessions subsequent to the delivery of product to them and such amounts are dependent on the end customer and product sales price. The price concessions are based on a variety of factors, including customer, product, quantity, geography and competitive differentiation. Price protection rights grant distributors the right to a credit in the event of declines in the price of the Company’s products. Under these circumstances, the Company remits back to the distributor a portion of their original purchase price after the resale transaction is completed in the form of a credit against the distributors’ outstanding accounts receivable balance. The credits are on a per unit basis and are not given to the distributor until the distributor provides information regarding the sale to their end customer. The Company estimates these credits and records such estimates in the same period the related revenue is recognized, resulting in a reduction of product revenue and the establishment of an allowance for price concessions due to distributors. The Company estimates credits to distributors based on the historical rate of credits provided to distributors relative to sales. Revenue on shipments to distributors is recorded when control of the products has been transferred to the distributor. The Company estimates the amount of its product sales that may be returned by its customers and records this estimate as a reduction of revenue in the period the related product revenue is recognized. The Company estimates its product return liability by analyzing its historical returns, current economic trends and changes in customer demand and acceptance of products. The Company has received insignificant returns to date and believes that returns of its products will continue to be minimal. At the time of shipment to distributors, the Company records a trade receivable for the selling price as there is a legally enforceable obligation of the distributor to pay for the product delivered, an allowance is recorded for the estimated discount that will be provided to the distributor, and the net of these amounts is recorded as revenue on the statement of operations. License Revenue For licenses of technology, recognition of revenue is dependent upon whether the Company has delivered rights to the technology, and whether there are future performance obligations under the contract. In some instances, the license agreements call for future events or activities to occur in order for milestones amounts to become due from the customer. The terms of such agreements include payment to the Company of one or more of the following: non-refundable upfront fees; and royalties on net sales of licensed products. Historically, these license agreements have not included other future performance obligations for the Company once the license has been transferred to the customer. Revenue from non-refundable up-front payments is recognized when the license is transferred to the customer and the Company has no other performance obligations. Royalties Revenue from sales-based royalties from licenses of the Company’s technology are recognized at the later of when (1) the sale occurs or (2) the performance obligation to which some or all of the sales-based royalty has been allocated is satisfied (in whole or in part). Other Revenue For certain revenue streams, the Company recognizes revenue based on the pattern of transfer of the services. The Company uses the input method of measuring costs incurred to date compared to total estimated costs to be incurred under the contract as this method most faithfully depicts its performance. The Company will record an unbilled receivable (within accounts receivable, net) for the portion of the work that has been completed but not invoiced at the end of each reporting period. Revenue from milestone payments must be estimated using either the expected value method or the most likely amount method. At the inception of each agreement that includes milestone payments, the Company evaluates whether the milestones are considered probable of being reached and estimates the amount to be included in the transaction price by using the most likely amount method. If it is probable that a significant reversal of cumulative revenue would not occur, the associated milestone value is included in the transaction price. At the end of each subsequent reporting period, the Company re-evaluates the probability or achievement of each such milestone and any related constraint, and if necessary, adjusts its estimate of the overall transaction price. Any such adjustments are recorded on a cumulative catch-up basis, which would affect revenues and earnings in the period of adjustment. Product Warranty The Company generally sells products with a limited warranty of product quality and a limited indemnification of customers against intellectual property infringement claims related to the Company’s products. The Company accrues for known warranty and indemnification issues if a loss is probable and can be reasonably estimated, and accrues for estimated losses incurred for unidentified issues based on historical experience. A warranty liability was not recorded at December 31, 2018 and 2017, as the estimated future warranty costs were not material based on the Company’s historical experience. Research and Development Research and development expenses are incurred in support of internal development programs or as part of our joint development agreement with GLOBALFOUNDRIES and joint collaboration agreement with Silterra Malaysia Sdn. Bhd. (see Note 10). Research and development expenses include personnel-related costs (including stock-based compensation), circuit design costs, purchases of materials and laboratory supplies, fabrication and packaging of experimental integrated circuit products, depreciation of research and development related capital equipment and overhead, and are expensed as incurred. Stock-based Compensation Stock-based compensation arrangements include stock option grants and restricted stock unit (RSU) awards under the Company’s equity incentive plans, as well as shares issued under the Company’s Employee Stock Purchase Plan (ESPP), through which employees may purchase the Company’s common stock at a discount to the market price. The Company measures its stock option grants made to employees based on the estimated fair value of the options as of the grant date using the Black-Scholes option-pricing model. Stock-based compensation expense is recognized over the requisite service period using the straight-line method. The Company has made an accounting policy election to account for forfeitures as they occur, rather than estimating expected forfeitures at the time of the grant. Stock-based compensation expense for options granted to non-employees as consideration for services received is measured on the date of performance at the fair value of the consideration received or the fair value of the equity instruments issued, using the Black-Scholes option-pricing model, whichever can be more reliably measured. Compensation expense for options granted to non-employees is periodically remeasured as the underlying options vest. Income Taxes The Company uses the liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are determined based on the differences between the financial reporting and the tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company must then assess the likelihood that the resulting deferred tax assets will be realized. A valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized. The Company recognizes benefits of uncertain tax positions if it is more likely than not that such positions will be sustained upon examination based solely on their technical merits, as the largest amount of benefit that is more likely than not to be realized upon the ultimate settlement. The Company’s policy is to recognize interest and penalties related to the underpayment of income taxes as a component of income tax expense or benefit. The Company does not have any unrecognized tax benefits. Net Loss per Common Share Basic net loss per common share is calculated by dividing the net loss by the weighted-average number of shares of common stock outstanding for the period less shares subject to repurchase, without consideration of potentially dilutive securities. Diluted net loss per common share is the same as basic net loss per common share since the effect of potentially dilutive securities is anti-dilutive. Prior Period Reclassifications Certain amounts in the prior period have been reclassified to conform with current period presentation. There was no impact on total revenue or net loss for the prior period. Recently Adopted Pronouncements ASU No. 2014-09, Revenue from Contracts with Customers In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2014‑09, Revenue from Contracts with Customers (Topic 606). Areas of revenue recognition that will be affected include, but are not limited to, transfer of control, variable consideration, allocation of transfer pricing, licenses, time value of money, contract costs and disclosures. The new standard permits adoption either by using (i) a full retrospective approach for all periods presented in the period of adoption or (ii) a modified retrospective approach with the cumulative effect of initially applying the new standard recognized at the date of initial application and providing certain additional disclosures. The new standard is effective for annual reporting periods beginning after December 15, 2017. The Company adopted this standard on January 1, 2018 using the modified retrospective method. The Company recognized the cumulative effect of initially applying the new revenue standard as an adjustment to the opening balance of its accumulated deficit. The comparative information has not been restated and continues to be reported under the accounting standards in effect for those periods. Topic 606 permits the application of certain practical expedients. The Company’s billing practices approximate the Company’s performance as measured by an output method, where each output represents the completion of a performance obligation. Accordingly, the Company utilizes the invoice practical expedient as defined in Topic 606, resulting in recognition of revenue in the amount that the Company has the right to invoice. Unsatisfied performance obligations primarily represent contracts for products with future delivery dates and with an original expected duration of one year or less. As allowed under Topic 606, the Company has opted to not disclose the amount of unsatisfied performance obligations as these contracts have original expected durations of less than one year. The Company incurs direct and incremental costs of obtaining contracts and such costs are expensed as incurred, as the life of the underlying contract is less than one year. Accordingly, the Company has concluded, based on the structure of its contracts, no adjustments are necessary under Topic 606. As a result of the adoption of the new standard, the Company changed its accounting policy for revenue recognition and the details of the significant changes and quantitative impact of the changes are disclosed below. Distributor sales – Some of the Company's contracts with distributors provide the distributor with certain concessions and price protection credits. Under Topic 605, Revenue, these concessions and price protection credits were not fixed or determinable and, as a result, the associated revenue was deferred until delivery of the product to the end customer. At the time of shipment to distributors, the Company recorded a trade receivable for the selling price as there was a legally enforceable obligation of the distributor to pay for the product delivered, inventory was reduced by the carrying value of goods shipped, and the net of these amounts, the gross profit, was recorded as deferred income on shipments to distributors on the balance sheet. Under Topic 606, the Company recognizes revenue from sales to distributors when control of the product is transferred to the distributor and estimates the amount of the concessions and price protection credits at the point of revenue recognition. Accordingly, the balance of the deferred income on shipments to distributors was eliminated as a cumulative effect adjustment of implementing Topic 606 as of January 1, 2018, net of the Company’s estimate of concessions and price protection credits for those contracts. Performance obligations delivered over time – Topic 605 permitted straight-line recognition of revenue for performance obligations that were delivered over time. The new revenue standard requires an entity to recognize revenue based on the pattern of transfer of the services. Entities must use either an input method or an output method to measure progress toward complete satisfaction of a performance obligation. The Company determined that the input method of measuring time elapsed to date compared to total estimated time to be incurred under the contract most faithfully depicts its performance. Under Topic 606, the Company will record an unbilled receivable (within accounts receivable, net) for the portion of the service that has been completed but not invoiced at the end of each reporting period. Milestone payments – Topic 605 permitted recognition using the milestone method, whereby revenue was recognized upon the completion of substantive milestones once the customers acknowledge the milestones have been met and the collection of the amounts is reasonably assured. The milestone method no longer exists under the new revenue standard. Revenue from milestone payments must be estimated using either the expected value method or the most likely amount method. If it is probable that a significant reversal of cumulative revenue would not occur, the associated milestone value is included in the transaction price. The adoption of Topic 606 did not have an impact on milestone revenue recorded to date as the practical expedient adopted for a single contract resulted in revenue recognition similar to milestone revenue under Topic 605. Sales-based royalties – Topic 605 permitted recognition of royalties when reported to the Company, which generally coincided with the receipt of payment. Under the new revenue standard, revenue generated from sales-based royalties from licenses of technology are recognized at the later of when (1) the sale occurs or (2) the performance obligation to which some or all of the sales-based royalty has been allocated is satisfied (in whole or in part). There was no impact to the recognition of revenue for non-refundable, up-front payments for licenses of the Company’s technology, which occurs when the license is transferred to the customer and there are no other performance obligations. The change in revenue recognition upon adoption of Topic 606 resulted in a decrease in the accumulated deficit balance of $1.3 million on January 1, 2018. The following table summarizes the impact of adopting Topic 606 on select balance sheet line items (in thousands): Balances without the adoption of December 31, 2018 As reported Adjustments Topic 606 Accounts receivable, net $ 7,522 $ (1,211) $ 6,311 Inventory 9,097 190 9,287 Total current assets 40,686 (1,021) 39,665 Total assets 45,045 (1,021) 44,024 Deferred income on shipments to distributors — 3,017 3,017 Total current liabilities 13,615 3,017 16,632 Total liabilities 20,124 3,017 23,141 Accumulated deficit (133,993) (4,038) (138,031) Total liabilities and stockholders’ equity 45,045 (1,021) 44,024 The following table summarizes the impact of adopting Topic 606 on select statement of operations line items (in thousands, except per share data): Results without the adoption of Year Ended December 31, 2018 As reported Adjustments Topic 606 Product sales $ 39,514 $ (2,915) $ 36,599 Licensing, royalty, and other revenue 9,903 (577) 9,326 Total revenue 49,417 (3,492) 45,925 Cost of sales 24,083 (754) 23,329 Gross profit 25,334 (2,738) 22,596 Loss from operations (17,321) (2,738) (20,059) Net loss and comprehensive loss (17,754) (2,738) (20,492) Net loss per common share, basic and diluted (1.08) (0.17) (1.25) The adoption had no impact to cash used in operating, investing or financing activities in the statement of cash flows. ASU No. 2017-09, Compensation-Stock Compensation In May 2017, the FASB issued ASU No. 2017-09, Compensation-Stock Compensation (Topic 718) Scope of Modification Accounting, which is intended to amend the scope of modification accounting for share-based payment arrangements. The amendments in the update provide guidance on types of changes to the terms or conditions of share-based payment awards that would require the Company to apply modification accounting under ASC 718, Compensation-Stock Compensation. This ASU is effective for annual reporting periods beginning after December 15, 2017, and early adoption was permitted. The Company adopted this standard on January 1, 2018, and the impact of its adoption on the Company’s financial statements was not material. ASU No. 2016-15, Statement of Cash Flows In August 2016, the FASB issued ASU No. 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments. ASU 2016-15 identifies how certain cash receipts and cash payments are presented and classified in the Statement of Cash Flows. The standard is effective for fiscal years and interim periods beginning after December 15, 2017. The standard should be applied retrospectively and early adoption was permitted, including adoption in an interim period. The Company adopted this standard on January 1, 2018, and the impact of its adoption on the Company’s financial statements was not material. Recently Issued Pronouncements In February 2016, the FASB issued ASU No. 2016‑02, Leases, which establishes a comprehensive new lease accounting model. The new standard: (a) clarifies the definition of a lease; (b) requires a dual approach to lease classification similar to current lease classifications; and (c) causes lessees to recognize leases on the balance sheet as a lease liability with a corresponding right-of-use asset for leases with a lease-term of more than twelve months. This ASU is effective for fiscal years and interim periods within those years beginning after December 15, 2018. In July 2018, the FASB issued ASU 2018-10, Codification Improvements to Topic 842 Leases and ASU No. 2018-11, Leases (Topic 842) Targeted Improvements. ASU 2018-10 clarifies how to apply certain aspects of ASU 2016-02. The Company will adopt this standard on January 1, 2019 using the modified retrospective method. The Company is substantially complete with its analysis as to the impact of adoption and estimates that the adoption will result in the recognition of right-of-use assets and lease liabilities for operating leases within the range of approximately $3.6 million to $4.0 million on its balance sheet, with no material impact to its statement of operations. In June 2016, the FASB issued ASU No. 2016-13, "Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which amends the incurred loss impairment methodology in current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. ASU 2016-13 is effective for annual reporting periods, and interim periods within those years, beginning after December 15, 2019, and requires a cumulative effect adjustment to the balance sheet as of the beginning of the first reporting period in which the guidance is effective. The Company is evaluating the impact of the adoption of ASU 2016-13 on its financial statements. In June 2018, the FASB issued ASU No. 2018‑07, Compensation-Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting. ASU 2018-07 is intended to reduce the cost and complexity and to improve financial reporting for nonemployee share based payment. The ASU expands the scope of Topic 718, (which currently only includes share-based payments to employees) to include share-based payments issued to nonemployees for goods or services. Consequently, the accounting for share-based payments to nonemployees and employees will be substantially aligned. The standard is effective for fiscal years beginning after December 15, 2018, including interim periods within that fiscal year. Early adoption is permitted,

Revenue

Revenue	12 Months Ended
	Dec. 31, 2018
Revenue
Revenue	3. Revenue The Company sells the majority of its products to its distributors, but does recognize some revenue under licensing and royalty agreements. The following table presents the Company’s revenues disaggregated by sales channel, (in thousands): Year Ended December 31, 2018 Distributor $ 35,126 Non-distributor 14,291 Total revenue $ 49,417 The following table presents the Company’s revenues disaggregated by timing of recognition (in thousands): Year Ended December 31, 2018 Point in time $ 45,102 Over time 4,315 Total revenue $ 49,417 The following table presents the Company’s revenues disaggregated by type (in thousands): Year Ended December 31, 2018 Product sales $ 39,514 License fees 5,000 Royalties 588 Other revenue 4,315 Total revenue $ 49,417 The Company recognizes revenue in three primary geographic regions: North America; Europe, Middle East and Africa (EMEA); and Asia-Pacific and Japan (APJ). The following table presents the Company’s revenues disaggregated by the geographic region to which the product is delivered or licensee is located (in thousands): Year Ended December 31, 2018 North America $ 9,124 EMEA 11,175 APJ 29,118 Total revenue $ 49,417

Balance Sheet Components

Balance Sheet Components	12 Months Ended
	Dec. 31, 2018
Balance Sheet Components
Balance Sheet Components	4. Balance Sheet Components Inventory Inventory consisted of the following (in thousands): December 31, 2018 2017 Raw materials $ 288 $ 682 Work-in-process 6,759 7,970 Finished goods 2,050 1,185 Total inventory $ 9,097 $ 9,837 Property and Equipment, Net Property and equipment, net consisted of the following (in thousands): December 31, 2018 2017 Manufacturing equipment $ 11,723 $ 10,465 Computer and network equipment 820 710 Furniture and fixtures 110 218 Software 680 455 Leasehold improvements 1,432 1,474 Total property and equipment, gross 14,765 13,322 Less: accumulated depreciation (10,479) (9,376) Total property and equipment, net $ 4,286 $ 3,946 Depreciation and amortization expense during the years ended December 31, 2018 and 2017 was $1.5 million and $1.2 million, respectively. Accrued Liabilities Accrued liabilities consisted of the following (in thousands): December 31, 2018 2017 Accrued payroll-related expenses $ 1,558 $ 1,331 Accrued joint development agreement expenses 661 749 Accrued inventory 1,678 897 Deferred rent 390 230 Accrued sales commissions payable to sales representatives 51 75 Other 663 466 Total accrued liabilities $ 5,001 $ 3,748

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2018
Commitments and Contingencies
Commitments and Contingencies	5. Commitments and Contingencies Operating Leases During 2017, the Company entered into a lease for 27,974 square feet of office space for its corporate headquarters located in Chandler, Arizona. The lease expires in January 2022, however the Company has the option to renew the lease through August 2024. Rent expense is recognized on a straight-line basis over the term of the leases and, accordingly, the Company records the difference between cash rent payments and the recognition of rent expense as a deferred rent liability. In April 2018, the Company entered into a lease termination agreement that released the Company from any further obligations on its previous headquarters’ space in Chandler, Arizona. The remaining unamortized balance of deferred rent of $18,000 was written off and a lease termination fee of $43,000 was recognized as rent expense on the statement of operations and comprehensive loss. The Company leases office and lab space for its design facility located in Austin, Texas. The lease expires in January 2022. The Company has another operating lease for its Arizona manufacturing facility, which includes office and fabrication space. This lease is cancellable upon 24 months’ notice by either of the parties. In March 2017, the Company amended the premises covered to remove laboratory space, decrease fabrication space and expand office space. In October 2017, the Company extended the lease through January 31, 2020, which could be further extended through January 31, 2021 if an option to extend is initiated by the lessor. In August 2018, the Company amended its lease agreement for its Arizona manufacturing facility to extend the lease term through January 2021. The following is a schedule of minimum rental commitments under the Company’s operating leases at December 31, 2018 (in thousands): Year Ending December 31, Amount 2019 $ 1,645 2020 1,701 2021 846 2022 47 2023 — Thereafter — Total minimum lease payments $ 4,239 Total rent expense was $1.6 million and $1.4 million for the years ended December 31, 2018 and 2017, respectively. Legal Proceedings From time to time, the Company may become involved in legal proceedings arising from the ordinary course of its business. Management is currently not aware of any matters that it expects will have a material adverse effect on the financial position, results of operations or cash flows of the Company. Indemnifications In the ordinary course of business, the Company enters into agreements that may include indemnification provisions. Pursuant to such agreements, the Company may indemnify, hold harmless and defend an indemnified party for losses suffered or incurred by the indemnified party. Some of the provisions will limit losses to those arising from third party actions. In some cases, the indemnification will continue after the termination of the agreement. The maximum potential amount of future payments the Company could be required to make under these provisions is not determinable. The Company has never incurred material costs to defend lawsuits or settle claims related to these indemnification provisions. The Company has also entered into indemnification agreements with its directors and officers that may require the Company to indemnify its directors and officers against liabilities that may arise by reason of their status or service as directors or officers to the fullest extent permitted by Delaware corporate law. The Company currently has directors’ and officers’ insurance.

Debt and Related Warrants

Debt and Related Warrants	12 Months Ended
	Dec. 31, 2018
Debt and Related Warrants
Debt and Related Warrants	6. Debt and Related Warrants Prior Facilities In June 2015, the Company executed a Loan and Security Agreement with Ares Venture Finance (2015 Credit Facility) comprising an $8.0 million term loan and a $4.0 million revolving loan. In April 2017, the Company repaid the outstanding balance of $1.1 million on the revolving loan at which time the unamortized balance of the debt discount of $10,000 was recognized as a loss on extinguishment of debt. In May 2017, the Company repaid the outstanding principal balance of $6.2 million on the term loan at which time the unamortized balance of the debt discount was $175,000, and paid a prepayment penalty of $61,000. The unamortized debt discount balance and the prepayment penalty were recognized as a loss on extinguishment of debt in the statements of operations and comprehensive loss. 2017 Credit Facility On May 4, 2017, the Company entered into a Loan and Security Agreement with Silicon Valley Bank (2017 Credit Facility) for a $12.0 million term loan. The term loan provided for interest at a floating rate equal to the prime rate minus 0.75%. The term loan provided for a period of interest-only payments through April 30, 2018, followed by fixed principal and interest payments based on either a 24-month amortization schedule or a 36-month amortization schedule if the Company met certain sales milestones. As of December 31, 2017, the Company determined it would not meet the sales milestones and as such the term loan was based on a 24-month amortization schedule. An end of term fee of 6% of the amount borrowed must be made when the loan is prepaid or repaid, whether at maturity or as a result of a prepayment or acceleration or otherwise. On July 6, 2018, the Company entered into the First Amendment to the 2017 Credit Facility (the Amended Credit Facility). The Amended Credit Facility extends the period of interest-only payments through December 31, 2018, followed by fixed principal and interest payments based on either a 24-month or a 36-month amortization schedule if the Company achieves certain milestones. The Company determined it would not meet the milestones, as such the Amended Credit Facility is based on a 24-month amortization schedule. The Amended Credit Facility provides for interest at a floating rate equal to the prime rate minus 0.75%. As of December 31, 2018, the interest rate was 4.75%. The terms of the Amended Credit Facility include the refund of $1.0 million in principal payments previously made by the Company. An end of term fee of 7% of the amount borrowed must be made when the loan is prepaid or repaid, whether at maturity or as a result of a prepayment or acceleration or otherwise. The additional payment is being accreted using the effective interest method. As of December 31, 2018, the effective interest rate under the Amended Credit Facility was 7.77%. Borrowings under the Amended Credit Facility mature in December 2020. Security for the Amended Credit Facility includes all of the Company’s assets except for intellectual property. The Company is required to comply with certain covenants under the Amended Credit Facility, including requirements to maintain a minimum liquidity ratio, meet certain revenue targets, and restrictions on certain actions without the consent of the lender, such as limitations on its ability to engage in mergers or acquisitions, sell assets, enter into transactions involving related parties, incur indebtedness or grant liens or negative pledges on its assets, make loans or make other investments. Under these covenants, the Company is prohibited from paying cash dividends with respect to its capital stock. The Company was in compliance with all covenants at December 31, 2018. The Amended Credit Facility contains a material adverse effect clause which provides that an event of default will occur if, among other triggers, an event occurs that could reasonably be expected to result in a material adverse effect on the Company’s business, operations or condition, or on the Company’s ability to perform its obligations under the term loan. As of December 31, 2018, management believes that it is remote that the clause will be triggered within the next twelve months, and therefore the term loan is classified as long-term. The carrying value of the Company’s Amended Credit Facility at December 31, 2018, was as follows (in thousands): Current Long-Term Portion Debt Total Credit Facility $ 6,000 $ 6,840 $ 12,840 Unamortized debt discounts (33) (341) (374) Net carrying value $ 5,967 $ 6,499 $ 12,466 The carrying value of the Company’s 2017 Credit Facility at December 31, 2017, was as follows (in thousands): Current Long-Term Portion Debt Total Credit Facility $ 4,000 $ 8,720 $ 12,720 Unamortized debt discounts (23) (563) (586) Net carrying value $ 3,977 $ 8,157 $ 12,134 The table below includes the principal repayments due under the Amended Credit Facility as of December 31, 2018 (in thousands): Principal Repayment as of December 31, 2018 2019 $ 6,000 2020 6,840 2021 — 2022 — 2023 — Total principal repayments $ 12,840 Capital Lease Obligations The Company leases certain equipment under capital lease obligations expiring in October 2020. The balance of the capital lease obligations was $20,000 and $31,000 at December 31, 2018 and 2017, respectively. Property and equipment under capital leases amounted to $31,000 at December 31, 2018 and 2017. Accumulated depreciation and amortization on these assets was $13,000 and $2,000 at December 31, 2018 and 2017, respectively. Future minimum rental commitments under the Company’s capital lease obligations are $10,000 for each of the years ended December 31, 2019 and 2020.

Stockholders' Equity

Stockholders' Equity	12 Months Ended
	Dec. 31, 2018
Stockholders’ Equity
Stockholders’ Equity	7. Stockholders’ Equity Common Stock Common stockholders are entitled to dividends if and when declared by the board of directors. As of December 31, 2018, no dividends on common stock had been declared by the board of directors. In February 2018, the Company completed a follow-on underwritten public offering of its common stock under its Registration Statement filed in November 2017 (File No. 333-221331), selling 3,772,447 shares of its common stock at an offering price of $7.00 per share for proceeds of $24.5 million, net of $1.9 million of underwriting discounts and commissions and other offering costs. The Company had reserved shares of common stock for future issuance as follows: December 31, 2018 2017 Options issued and outstanding 1,475,299 1,593,195 Shares available for future option grants 764,145 83,929 RSUs subject to future vesting 93,560 30,680 Common stock warrants 27,836 27,690 Total 2,360,840 1,735,494 Warrants In connection with a credit facility, Silicon Valley Bank held warrants to purchase 9,229 shares of the Company’s common stock at an exercise price of $26.00 per share. These warrants were cancelled when the Company entered into the Amended Credit Facility (see Note 6) and the Company subsequently issued a warrant to SVB for the purchase of 9,375 shares of the Company’s common stock at an exercise price of $8.91 per share. The warrant can be exercised at any time and expires five years after the date of issuance. The Company estimated the fair value of the warrant as $43,000 on the date of issuance using the Black-Scholes option pricing model. The warrant was recorded as a discount to the debt and will be amortized into interest expense over the remaining term of the loan using the effective interest method. In connection with the 2015 Credit Facility, Ares Venture Finance holds a warrant to purchase 18,461 shares of the Company’s common stock at an exercise price of $26.00 per share. The warrant can be exercised at any time and expires 10 years after the date of issuance.

Stock-Based Compensation

Stock-Based Compensation	12 Months Ended
	Dec. 31, 2018
Stock-Based Compensation
Stock-Based Compensation	8. Stock-Based Compensation 2016 Employee Incentive Plan The Company’s board of directors adopted the 2016 Equity Incentive Plan (the 2016 Plan) on April 25, 2016, which was subsequently approved on September 20, 2016 by the Company’s stockholders. The 2016 Plan became effective on October 7, 2016, the date the Company’s registration statement was declared effective by the SEC. The Company’s 2016 Plan provides for the grant of incentive stock options, nonstatutory stock options, stock appreciation rights, restricted stock awards, restricted stock unit awards, performance-based stock awards, and other forms of equity compensation to employees, directors and consultants. In addition, the Company’s 2016 Plan provides for the grant of performance cash awards to employees, directors and consultants. The maximum number of shares of common stock that may be issued under the Company’s 2016 Plan is 500,000 subject to an automatic increase on January 1 of each year, beginning on January 1, 2017, and continuing through and including January 1, 2026, by 3% of the total number of shares of capital stock outstanding on December 31 of the preceding calendar year, or a lesser number of shares determined by the Company’s board of directors. 2008 Employee Incentive Plan The 2008 Equity Incentive Plan (the 2008 Plan) provided for the issuance of incentive stock options (ISO), nonqualified stock options, and other stock compensation awards. Under the terms of the 2008 Plan, the exercise price of an ISO shall be not less than 100% of the fair value of the stock at the date of grant, as determined by the board of directors, or in the case of certain ISOs, at 110% of the fair market value at the date of grant. The term and vesting periods for options granted under the 2008 Plan were determined by the Company’s board of directors. Options granted generally vest over four years. Options must be exercised within a 10‑year period or sooner if so specified within the option agreement. No further grants will be made under the Company’s 2008 Plan. However, any outstanding stock awards granted under the 2008 Plan will remain outstanding, subject to the terms of the Company’s 2008 Plan and the applicable stock award agreements, until such outstanding stock awards that are stock options are exercised or until they terminate or expire by their terms, or until such stock awards are fully settled, terminated or forfeited. At December 31, 2018, 407,780 options under the 2008 Plan remained outstanding. Summary of Stock Option Activity The following table summarizes the stock option and award activity for all grants under the 2008 Plan and 2016 Plan: Options Outstanding Weighted- Weighted- Options and Average Average Awards Exercise Remaining Aggregate Available for Number of Price Per Contractual Intrinsic Grant Options Share Life (years) Value (In thousands) Balance—December 31, 2017 83,929 1,593,195 $ 8.88 6.6 $ 1,997 Immaterial prior period adjustment (1,026) 11,477 4.84 Authorized 1,084,516 — — RSUs granted (80,950) — — RSUs cancelled/forfeited 3,000 — — Options granted (434,665) 434,665 8.52 Options exercised — (448,411) 4.99 $ 1,915 Options cancelled/forfeited 109,341 (115,627) 8.68 Balance—December 31, 2018 764,145 1,475,299 $ 7.60 7.8 $ 284 Options exercisable—December 31, 2018 617,718 $ 6.79 6.4 $ 276 During the years ended December 31, 2018 and 2017, the Company granted options with a weighted-average grant date fair value of $4.45 and $6.48 per share, respectively. The total fair value of options vested during the year was $1.9 million and $1.5 million, for the years ended December 31, 2018, and 2017, respectively. 2016 Employee Stock Purchase Plan The Company’s board of directors adopted the 2016 Employee Stock Purchase Plan (the ESPP) on April 25, 2016, which was subsequently approved on September 20, 2016 by the Company’s stockholders. The purpose of the ESPP is to secure the services of new employees, to retain the services of existing employees and to provide incentives for such individuals to exert maximum efforts toward the Company’s success and that of the Company’s affiliates. The ESPP is intended to qualify as an “employee stock purchase plan” within the meaning of Section 423 of the Code. The board of directors, or a duly authorized committee thereof, will administer the Company’s ESPP. The maximum aggregate number of shares of common stock that may be issued pursuant to the exercise of purchase rights under the Company’s ESPP that are granted to employees or to employees of any of the Company’s designated affiliates is 96,153 shares, subject to annual increases. The number of shares of common stock reserved for issuance under the Company’s ESPP will increase automatically each year, beginning on January 1, 2017, and continuing through and including January 1, 2026, by 1% of the total number of shares of common stock outstanding on December 31 of the preceding calendar year, or a lesser number as determined by the board of directors. In 2018 and 2017, there was an increase of 128,172 and 124,981 shares, respectively, reserved for issuance under the Company’s ESPP due to this provision. Shares subject to purchase rights granted under the Company’s ESPP that terminate without having been exercised in full will not reduce the number of shares available for issuance under the Company’s ESPP. There are two offering periods each year and each offering under the ESPP will consist of two purchase periods of approximately six months in duration and will run concurrently. The Company had 269,389 shares available for issuance under the Company’s ESPP as of December 31, 2018. Employees purchased 42,327 shares for $266,000 during the year ended December 31, 2018 and 37,590 shares for $256,000 during the year ended December 31, 2017. The following table summarizes the assumptions used in the Black-Scholes option-pricing model to determine fair value of the Company’s common shares issued under the ESPP: Year Ended December 31, 2018 2017 Expected volatility 59.5 – 87.8 % 49.3 – 72.7 % Risk-free interest rate 0.94 – 2.11 % 0.49 – 1.02 % Expected term (in years) 0.5 – 1.0 0.5 – 1.0 Dividend yield — % — % Modification of Stock-Based Awards In February 2018, the Company modified the terms of 400,000 vested and unvested stock option awards granted to the Chief Executive Officer, by reducing their exercise price from $16.25 per share to $7.64 per share. There was no change to any of the other terms of the option awards. The modification resulted in an incremental value of $600,000 being allocated to the options, of which $63,000 was recognized to expense immediately based on options that were vested at the time of the modification. The remaining incremental value of $537,000 attributable to unvested options will be recognized over the remaining vesting term through September 2021. In August 2017, the Company entered into a Separation Agreement with its former Chief Executive Officer which resulted in the acceleration in the vesting of certain unvested stock options as well as the extension of the exercise period for all vested options. As a result of the modification, the Company recorded stock-based compensation expense of $310,000 during the year ended December 31, 2017 to reflect the revised service period for the stock options and related vesting of shares that would otherwise not have vested. Restricted Stock Units In September 2017, the Company’s board of directors authorized the issuance of Restricted Stock Units (RSUs), under the 2016 Plan and adopted a form of Restricted Stock Unit Award Agreement, which is intended to serve as a standard form agreement for RSU grants issued to employees, executive officers, directors and consultants. The fair value of the RSUs is recognized as expense ratably over the vesting period, as determined by the board of directors on the date of grant. The following table summarizes RSU activity for the year ended December 31, 2018: RSUs Outstanding Weighted- Average Number of Grant Date Restricted Stock Fair Value Per Units Share Balance—December 31, 2017 30,680 $ 10.55 Granted 80,950 8.48 Vested (15,070) 13.41 Cancelled/forfeited (3,000) 8.10 Balance—December 31, 2018 93,560 $ 8.38 The fair value of RSUs is determined on the date of grant based on the market price of the Company’s common stock on that date. As of December 31, 2018, there was $594,000 of unrecognized stock-based compensation expense related to RSUs to be recognized over a weighted-average period of 2.7 years. Stock-based Compensation Expense The Company recognized stock-based compensation expense from awards granted to employees and non-employees under its equity incentive plans and from its ESPP as follows, excluding amounts related to GLOBALFOUNDRIES, Inc. (GF) (in thousands): Year Ended December 31, 2018 2017 Research and development $ 492 $ 488 General and administrative 1,811 1,297 Sales and marketing 365 263 Total $ 2,668 $ 2,048 As of December 31, 2018, there was $4.8 million of total unrecognized compensation expense related to unvested options which the Company expects recognize over a weighted-average period of 2.7 years. Compensation cost capitalized within inventory at December 31, 2018 and 2017 was not material. Employee Stock-based Compensation Stock-based compensation expense for employees was $2.6 million and $2.0 million, for the years ended December 31, 2018 and 2017, respectively. The Company estimated the fair value of each option grant using the Black-Scholes option-pricing model. The fair value of employee stock options is being amortized on a straight-line basis over the requisite service period of the awards. The fair value of employee stock options was estimated using the assumptions below. Year Ended December 31, 2018 2017 Expected volatility 51.9 – 56.6 % 46.7 – 52.0 % Risk-free interest rate 2.64 - 2.94 % 1.85 - 2.14 % Expected term (in years) 5.7 – 6.1 5.3 – 6.1 Dividend yield — % — % Expected volatility. Since the Company does not have a sufficient trading history for its common stock, the expected volatility was derived from the average historical volatilities of publicly traded companies within a similar industry that are considered to be comparable to the Company’s business over a period approximately equal to the expected term for employees’ options. Risk-free interest rate. The risk-free interest rate is based on the U.S. Treasury yield with a maturity equal to the expected term of the option in effect at the time of grant. Expected term. The expected term represents the period that the stock-based awards are expected to be outstanding. The Company used the simplified method to determine the expected term, which is calculated as the average of the time to vesting and the contractual life of the options. Dividend yield. The Company has never paid dividends on its common stock and is prohibited from paying dividends on its common stock. Therefore, the Company used an expected dividend yield of zero. Non-employee Stock-based Compensation Stock-based compensation expense related to stock options granted to non-employees is recognized as the stock options vest. During the year ended December 31, 2018, the Company granted options to purchase 8,400 shares of common stock to non-employees with a weighted-average exercise price of $8.91 per share. During the year ended December 31, 2017, the Company granted options to purchase 16,800 shares of common stock to non-employees with a weighted-average exercise price of $13.74 per share. Options to purchase 43,865 shares and 37,872 shares of common stock were outstanding with a weighted-average exercise price of $9.25 and $9.16 per share as of December 31, 2018 and 2017, respectively. Stock-based compensation expense for non-employees was $31,000 and $69,000 for the years ended December 31, 2018 and 2017, respectively. The Company believes that the fair value of the stock options is more reliably measurable than the fair value of services received. The fair value of the stock options granted is calculated at each reporting date using the Black-Scholes option pricing model with the following assumptions:  Year Ended December 31, 2018 2017 Expected volatility 52.9 – 54.8 % 46.7 – 60.5 % Risk-free interest rate 2.68 - 2.97 % 2.09 – 2.44 % Expected term (in years) 8.0 – 8.8 7.2 – 9.6 Dividend yield — % — %

401 (k) Plan

401 (k) Plan	12 Months Ended
	Dec. 31, 2018
401 (k) Plan
401 (k) Plan	9. 401(k) Plan The Company has a defined contribution employee benefit plan pursuant to Section 401(k) of the Internal Revenue Code. The plan allows eligible employees to defer a portion of their annual compensation up to certain statutory limits. At the election of the Board of Directors, the Company may elect to match employee contributions but has not done so to date.

Significant Agreements

Significant Agreements	12 Months Ended
	Dec. 31, 2018
Significant Agreements
Significant Agreements	10. Significant Agreements GLOBALFOUNDRIES, Inc. Joint Development Agreement On October 17, 2014, the Company entered into a Joint Development Agreement (JDA) with GF for the joint development of the Company’s Spin Transfer Torque MRAM (STT-MRAM) technology. The term of the agreement is the later of four years from the effective date or until the completion, termination or expiration of the last statement of work entered into pursuant to the JDA. The JDA also states that the specific terms and conditions for the production and supply of the developed STT-MRAM technology would be pursuant to a separate manufacturing agreement entered into between the parties. In October 2018, the Company entered into the Third Amendment to the JDA with GF, which extended the term of the JDA until December 2019. Under the JDA, each party licenses its relevant intellectual property to the other party. For certain jointly developed works, the parties have agreed to follow an invention allocation procedure to determine ownership. In addition, GF possesses the exclusive right to manufacture the Company’s discrete and embedded STT-MRAM devices developed pursuant to the agreement until the earlier of three years after the qualification of the MRAM device for a particular technology node or four years after the completion of the relevant statement of work under which the device was developed. For the same exclusivity period associated with the relevant device, GF agreed not to license intellectual property developed in connection with the JDA to named competitors of the Company. Generally, unless otherwise specified in the agreement or a statement of work, the Company and GF share project costs, which do not include personnel or production qualification costs, under the JDA. If GF manufactures, sells or transfers to customers wafers containing production quantified STT-MRAM devices that utilize certain design information, GF will be required to pay the Company a royalty. The Company incurred project costs, recognized as research and development expense, of $5.8 million and $5.2 million during the years ended December 31, 2018 and 2017, respectively. The Company entered into a Statement of Work (SOW) and an Amendment to the SOW, under the JDA with GF effective August 2016 and June 2018 respectively. The Company is entitled to revenues under the SOW and its Amendment upon delivery and acceptance of product. The Company recognized revenue from GF of $1.0 million and $1.6 million for the year ended December 31, 2018 and 2017 respectively. On October 21, 2014, GF participated, along with other investors, in the Company’s Series B redeemable convertible preferred stock financing and purchased 192,307 shares at $26.00 per share. Contemporaneously, the Company sold 461,538 shares of its common stock to GF at a discounted price of $0.00026 per share. The common shares vest upon the achievement of a goal as set forth in the Statement of Work #1 (the SOW) under the JDA. The Company has determined that the issuance of these shares of common stock to GF represents compensation for services to be provided under the JDA. Accordingly, the shares are accounted for similar to a stock award granted to a non-employee of the Company and are remeasured to their fair value as they vest. A total of 211,538 shares of common stock became vested on August 21, 2016, the designated Initial Measurement Date. The remaining shares vest on a monthly basis thereafter through October 21, 2018. As of December 31, 2018, all shares issued to GF were fully vested. During the years ended December 31, 2018 and 2017, the Company recognized non-cash compensation expense of $0.8 million and $1.5 million, respectively, in research and development expense, related to the vesting of the shares of common stock. Silterra Malaysia Sdn. Bhd. Joint Collaboration Agreement In September 2018, the Company entered into a Joint Collaboration Agreement (JCA) with Silterra Malaysia Sdn. Bhd. (Silterra), and another third party. The JCA will create additional manufacturing capacity for the Company’s Toggle MRAM products. Initial production is expected to start in 2020. Under the JCA the Company will pay non-recurring engineering costs of $1.0 million. During the year ended December 31, 2018, the Company paid $0.8 million of JCA costs. License Agreement In March 2018, the Company entered into a global cross-license agreement with a customer pursuant to which the Company granted a worldwide, non-exclusive, non-transferable, irrevocable, royalty-bearing license under the Company’s patents to use, sell, import and export the Company’s products. Under the cross-license agreement, the Company received a non-refundable license fee and is entitled to quarterly royalty payments based upon low single digits of the average selling price of products covered under the license agreement. The license was transferred to the customer and the Company recognized revenue related to the non-refundable license fee during the year ended December 31, 2018. The cross-license agreement will remain in effect until the licensed patents have expired, been abandoned, or ruled invalid.

Geographic Information

Geographic Information	12 Months Ended
	Dec. 31, 2018
Geographic Information
Geographic Information	11. Geographic Information Property and equipment, net by country was as follows (in thousands): December 31, 2018 2017 United States $ 2,714 $ 2,594 Singapore 912 696 Taiwan 258 656 Other 402 — $ 4,286 $ 3,946 Revenue from customers is designated based on the geographic region or country to which the product is delivered or licensee is located. Revenue by country was as follows (in thousands): Year Ended December 31, 2018 2017 Japan $ 10,254 $ 4,128 Germany 6,724 2,964 United States 6,746 4,759 China 5,083 2,588 Singapore 3,818 8,067 All other 16,792 13,430 Total revenue $ 49,417 $ 35,936

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2018
Income Taxes
Income Taxes	12. Income Taxes For the years ended December 31, 2018 and 2017, the Company recorded no provision or benefit for income taxes primarily due to losses incurred. The Company has incurred net operating losses for all the periods presented. The reconciliation of the statutory federal income tax rate to the Company’s effective tax rate is as follows: Year Ended December 31, 2018 2017 Tax at statutory federal rate (21.0) % (34.0) % State taxes, net of federal benefit (1.7) (1.4) Stock-based compensation 1.5 (0.8) Nondeductible executive compensation 0.9 — Change in valuation allowance 20.6 (34.2) Federal tax rate change — 70.2 Other (0.3) 0.2 Provision for income taxes (0.0) % (0.0) % The tax effects of temporary differences and carryforwards that give rise to significant portions of the deferred tax assets are as follows (in thousands): December 31, 2018 2017 Deferred tax assets: Net operating loss carryforwards $ 25,359 $ 22,586 Inventory 1,442 1,520 Accruals 760 401 Depreciation and amortization 88 60 Limitation on business interest 96 — Stock-based compensation 1,416 1,228 Gross deferred tax assets 29,161 25,795 Valuation allowance (29,073) (25,721) Deferred tax assets 88 74 Deferred tax liabilities: Prepaid expenses (88) (74) Deferred tax liabilities (88) (74) Net deferred tax assets $ — $ — The Company is required to reduce its deferred tax assets by a valuation allowance if it is more likely than not that some or all of its deferred tax assets will not be realized. Management must use judgment in assessing the potential need for a valuation allowance, which requires an evaluation of both negative and positive evidence. The weight given to the potential effect of negative and positive evidence should be commensurate with the extent to which it can be objectively verified. In determining the need for and amount of the valuation allowance, if any, the Company assesses the likelihood that it will be able to recover its deferred tax assets using historical levels of income, estimates of future income and tax planning strategies. As a result of historical cumulative losses, the Company determined that, based on all available evidence, there was substantial uncertainty as to whether it will recover recorded net deferred taxes in future periods. Accordingly, the Company recorded a valuation allowance against all of its net deferred tax assets as of December 31, 2018 and 2017. In 2018, there was no utilization of the valuation allowance and the net valuation allowance increased by $3.4 million. In 2017, the valuation allowance decreased by $7.1 million, from the December 31, 2016 balance of $32.8 million, due to the Tax Cuts and Jobs Act, which was enacted in December 2017 and reduced the corporate tax rate from 34% to 21%. The rate reduction took effect on January 1, 2018. The carrying value of the Company’s deferred tax assets is also determined by the enacted US corporate income tax rate. As of December 31, 2018, the Company had federal net operating loss carryforwards of approximately $112.3 million, of which $99.7 million will begin to expire in the year of 2028 if not utilized, and $12.6 million will carryover indefinitely. In addition, the Company had state net operating loss carryforwards of approximately $44.3 million, of which $43.5 million will begin to expire in 2023 if not utilized, and $0.8 million will carryover indefinitely. The Tax Reform Act of 1986 (the Act) provides for a limitation on the annual use of net operating loss and research and development tax credit carryforwards following certain ownership changes (as defined by the Act) that could limit the Company’s ability to utilize these carryforwards. The Company files income tax returns in the U.S. federal and various state jurisdictions. The Company is subject to U.S. federal and state income tax examinations by authorities for all tax years beginning in 2008, due to the accumulated net operating losses that are being carried forward for tax purposes. The Company has not identified any unrecognized tax benefits as of December 31, 2018 and 2017. As the Company has a full valuation allowance on its deferred tax assets, any unrecognized tax benefits would reduce the deferred tax assets and the valuation allowance in the same amount. The Company does not expect the amount of unrecognized tax benefits to materially change in the next twelve months.

Net Loss Per Common Share

Net Loss Per Common Share	12 Months Ended
	Dec. 31, 2018
Net Loss Per Common Share
Net Loss Per Common Share	13. Net Loss Per Common Share The following table sets forth the computation of basic and diluted net loss per share (in thousands, except share and per share amounts): Year Ended December 31, 2018 2017 Numerator: Net loss $ (17,754) $ (21,100) Denominator: Weighted-average common shares outstanding 16,413,733 12,640,094 Less: weighted-average unvested common shares subjected to repurchase (41,095) (155,110) Weighted-average common shares outstanding used to calculate net loss per common share, basic and diluted 16,372,638 12,484,984 Net loss per common share, basic and diluted $ (1.08) $ (1.69) The following outstanding shares of potentially dilutive securities have been excluded from diluted net loss per common share for the periods presented, because their inclusion would be anti-dilutive: Year Ended December 31, 2018 2017 Options to purchase common stock 1,475,299 1,593,195 Restricted stock units 93,560 30,680 Common stock subject to repurchase — 96,153 Common stock warrants 27,836 27,690 Total 1,596,695 1,747,718

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2018
Summary of Significant Accounting Policies
Use of Estimates	Use of Estimates The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP). The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. On an ongoing basis, management evaluates its estimates, including those related to revenue recognition, fair value of assets and liabilities, inventory, product warranty reserves, income taxes, and stock-based compensation. The Company believes its estimates and assumptions are reasonable; however, actual results may differ from the Company’s estimates.
Segments	Segments The Company’s chief operating decision maker is its Chief Executive Officer who reviews financial information presented on a consolidated basis for purposes of allocating resources and evaluating financial performance for the entire Company. As a result, the Company has single operating and reportable segment..
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all highly liquid, short-term investments with maturity dates of 90 days or less at the date of purchase to be cash equivalents. The Company’s cash equivalents consist solely of money market funds.
Accounts Receivable	Accounts Receivable Accounts receivable are recorded at the invoiced amount and do not bear interest. The Company generally does not require collateral or other security in support of accounts receivable. Allowances are provided for individual accounts receivable when the Company becomes aware of a customer’s inability to meet its financial obligations, such as in the case of bankruptcy, deterioration in the customer’s operating results or change in financial position. If circumstances related to customers change, estimates of the recoverability of receivables would be further adjusted. The Company also considers a number of factors in evaluating the sufficiency of its allowance for doubtful accounts, including the length of time receivables are past due, significant one-time events, creditworthiness of customers and historical experience. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. At December 31, 2018 and 2017, there was no allowance for doubtful accounts. The Company establishes an allowance for product returns. The Company analyzes historical returns, current economic trends and changes in customer demand and acceptance of products when evaluating the adequacy of sales returns. As the returns are processed as credits on future purchases, the allowance is recorded against the balance of trade accounts receivable. In addition, the Company establishes an allowance for estimated price concessions related to its distributer agreements. The Company estimates credits to distributors based on the historical rate of credits provided to distributors relative to sales. The allowance for product returns and the allowance for price concessions were $144,000 and $569,000 at December 31, 2018, respectively, and $147,000 and $0 at December 31, 2017, respectively. Accounts receivable, net consisted of the following (in thousands): December 31, 2018 2017 Trade accounts receivable $ 7,297 $ 4,188 Unbilled accounts receivable 938 — Allowance for accounts receivable (713) (147) Accounts receivable, net $ 7,522 $ 4,041
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially expose the Company to a concentration of credit risk consist principally of cash and cash equivalents that are held by a financial institution in the United States and accounts receivable. Amounts on deposit with a financial institution may at times exceed federally insured limits. The Company maintains its cash accounts with high credit quality financial institutions and accordingly, minimal credit risk exists with respect to the financial institutions. Significant customers are those which represent more than 10% of the Company’s total revenue or net accounts receivable balance at each respective balance sheet date. For the purposes of this disclosure, the Company defines “customer” as the entity that is purchasing the products or licenses directly from the Company, which includes the distributors of the Company’s products in addition to end customers that the Company sells to directly. For each significant customer, revenue as a percentage of total revenue and accounts receivable as a percentage of total accounts receivable, net are as follows: Revenue Accounts Receivable, net Year Ended As of December 31, December 31, Customers 2018 2017 2018 2017 Customer A 13 % 16 % * * Customer B 11 % * * * Customer C 10 % * * 11 % Customer D * 15 % * * Customer E * * 23 % * Customer F * * 21 % * Customer G * * 11 % 15 % Customer H * * 11 % * Customer I * * * 10 % *
Inventory	Inventory Inventory is valued at the lower of cost, using the first-in, first-out or specific identification method, or market. The carrying value of inventory is adjusted for excess and obsolete inventory based on inventory age, shipment history and the forecast of demand over a specific future period. At the point of loss recognition, a new lower cost basis for that inventory is established and subsequent changes in facts and circumstances do not result in the restoration or increase in that new cost basis.
Fair Value of Financial Instruments	Fair Value of Financial Instruments Fair value is defined as an exit price, representing the amount that would be received to sell an asset, or paid to transfer a liability, in an orderly transaction between market participants. The framework for measuring fair value provides a three-tier hierarchy prioritizing inputs to valuation techniques used in measuring fair value as follows: Level 1 — Observable inputs such as quoted prices for identical assets or liabilities in active markets; Level 2 — Inputs, other than quoted prices for identical assets or liabilities in active markets, which are observable either directly or indirectly; and Level 3 — Unobservable inputs in which there is little or no market data requiring the reporting entity to develop its own assumptions. The carrying value of accounts receivable, accounts payable, and other accruals readily convertible into cash approximate fair value because of the short-term nature of the instruments. As of December 31, 2018, based on Level 2 inputs and the borrowing rates available to the Company for loans with similar terms and consideration of the Company’s credit risk, the carrying value of the Company’s variable interest rate debt, excluding unamortized debt issuance costs, approximates fair value. The Company’s financial instruments consist of Level 1 assets. Where quoted prices are available in an active market, securities are classified as Level 1. Level 1 assets consist of highly liquid money market funds that are included in cash equivalents. The following tables sets forth the fair value of the Company’s financial assets measured at fair value on a recurring basis (in thousands): December 31, 2018 Level 1 Level 2 Level 3 Total Assets: Money market funds $ 23,478 $ — $ — $ 23,478 Total assets measured at fair value $ 23,478 $ — $ — $ 23,478 December 31, 2017 Level 1 Level 2 Level 3 Total Assets: Money market funds $ 13,369 $ — $ — $ 13,369 Total assets measured at fair value $ 13,369 $ — $ — $ 13,369
Property and Equipment	Property and Equipment Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation begins at the time the asset is placed in service. Maintenance and repairs are charged to operations as incurred. Depreciation is computed using the straight-line method over the following estimated useful lives of the assets: Useful Lives Computer and network equipment 2 years Manufacturing equipment 2 – 7 years Furniture and fixtures 7 years Software 3 years Leasehold improvements are amortized over the shorter of the lease term or useful life. Upon sale or retirement of assets, the cost and related accumulated depreciation are removed from the balance sheet and the resulting gain or loss is reflected in operations. Amortization expense of assets acquired through capital leases is included in the statements of operations and comprehensive loss.
Impairment of Long-lived Assets	Impairment of Long-lived Assets The Company evaluates its long-lived assets, including property and equipment, for impairment whenever events or changes in circumstances indicate that the carrying value of these assets may not be recoverable. Recoverability of these assets is measured by comparison of the carrying amount of each asset to the future undiscounted cash flows the asset is expected to generate over its remaining life. If the asset is considered to be impaired, the amount of any impairment is measured as the difference between the carrying value and the fair value of the impaired asset. There have been no impairments of the Company’s long-lived assets during any of the periods presented.
Leases	Leases The Company leases office, lab, and manufacturing space in various locations. Rent expense under operating leases is recognized on a straight-line basis over the lease term taking into consideration rent abatements, scheduled rent increases and any lease incentives.
Debt Issuance Costs	Debt Issuance Costs The Company defers and amortizes issuance costs, underwriting fees, end of term payments, and related expenses incurred in connection with the issuance of debt instruments using the effective interest method over the terms of the respective instruments. Debt issuance costs are reflected as a direct reduction of the carrying amount of the related debt liability.
Revenue Recognition	Revenue Recognition The Company recognizes revenue when a customer obtains control of the promised products or services, in an amount that reflects the consideration the Company expects to receive in exchange for those products or services. Revenue is recognized net of allowances for returns and price concessions, and any taxes collected from customers, which are subsequently remitted to governmental authorities. Nature of Products and Services The Company’s revenue is derived from the sale of MRAM-based products in discrete unit form, licenses of and royalties on its MRAM and magnetic sensor technology, the sale of backend foundry services and design services to third parties. Sales of products in discrete unit form are recognized at a point in time, revenue related to licensing agreements is recognized when the Company has delivered control of the technology, revenue related to royalty agreements is recognized in the period in which sales generated from products sold using the Company’s technology occurs, sales of backend foundry services are recognized over time, and design services to third parties are recognized either at a point in time or over time, depending on the nature of the services. Product Revenue For products sold in their discrete form, the Company either sells its products directly to original equipment manufacturers (OEMs), original design manufacturers (ODMs) and contract manufacturers (CMs), or through a network of distributors, who in turn sell to those customers. For sales directly to OEMs, ODMs and CMs, revenue is recognized when the OEM, ODM or CM obtains control of the product, which occurs at a point in time, generally upon shipment to the customer. The Company sells the majority of its products to its distributors at a uniform list price. However, distributors may resell the Company’s products to end customers at a very broad range of individually negotiated price points. Distributors are provided with price concessions subsequent to the delivery of product to them and such amounts are dependent on the end customer and product sales price. The price concessions are based on a variety of factors, including customer, product, quantity, geography and competitive differentiation. Price protection rights grant distributors the right to a credit in the event of declines in the price of the Company’s products. Under these circumstances, the Company remits back to the distributor a portion of their original purchase price after the resale transaction is completed in the form of a credit against the distributors’ outstanding accounts receivable balance. The credits are on a per unit basis and are not given to the distributor until the distributor provides information regarding the sale to their end customer. The Company estimates these credits and records such estimates in the same period the related revenue is recognized, resulting in a reduction of product revenue and the establishment of an allowance for price concessions due to distributors. The Company estimates credits to distributors based on the historical rate of credits provided to distributors relative to sales. Revenue on shipments to distributors is recorded when control of the products has been transferred to the distributor. The Company estimates the amount of its product sales that may be returned by its customers and records this estimate as a reduction of revenue in the period the related product revenue is recognized. The Company estimates its product return liability by analyzing its historical returns, current economic trends and changes in customer demand and acceptance of products. The Company has received insignificant returns to date and believes that returns of its products will continue to be minimal. At the time of shipment to distributors, the Company records a trade receivable for the selling price as there is a legally enforceable obligation of the distributor to pay for the product delivered, an allowance is recorded for the estimated discount that will be provided to the distributor, and the net of these amounts is recorded as revenue on the statement of operations. License Revenue For licenses of technology, recognition of revenue is dependent upon whether the Company has delivered rights to the technology, and whether there are future performance obligations under the contract. In some instances, the license agreements call for future events or activities to occur in order for milestones amounts to become due from the customer. The terms of such agreements include payment to the Company of one or more of the following: non-refundable upfront fees; and royalties on net sales of licensed products. Historically, these license agreements have not included other future performance obligations for the Company once the license has been transferred to the customer. Revenue from non-refundable up-front payments is recognized when the license is transferred to the customer and the Company has no other performance obligations. Royalties Revenue from sales-based royalties from licenses of the Company’s technology are recognized at the later of when (1) the sale occurs or (2) the performance obligation to which some or all of the sales-based royalty has been allocated is satisfied (in whole or in part). Other Revenue For certain revenue streams, the Company recognizes revenue based on the pattern of transfer of the services. The Company uses the input method of measuring costs incurred to date compared to total estimated costs to be incurred under the contract as this method most faithfully depicts its performance. The Company will record an unbilled receivable (within accounts receivable, net) for the portion of the work that has been completed but not invoiced at the end of each reporting period. Revenue from milestone payments must be estimated using either the expected value method or the most likely amount method. At the inception of each agreement that includes milestone payments, the Company evaluates whether the milestones are considered probable of being reached and estimates the amount to be included in the transaction price by using the most likely amount method. If it is probable that a significant reversal of cumulative revenue would not occur, the associated milestone value is included in the transaction price. At the end of each subsequent reporting period, the Company re-evaluates the probability or achievement of each such milestone and any related constraint, and if necessary, adjusts its estimate of the overall transaction price. Any such adjustments are recorded on a cumulative catch-up basis, which would affect revenues and earnings in the period of adjustment.
Product Warranty	Product Warranty The Company generally sells products with a limited warranty of product quality and a limited indemnification of customers against intellectual property infringement claims related to the Company’s products. The Company accrues for known warranty and indemnification issues if a loss is probable and can be reasonably estimated, and accrues for estimated losses incurred for unidentified issues based on historical experience. A warranty liability was not recorded at December 31, 2018 and 2017, as the estimated future warranty costs were not material based on the Company’s historical experience.
Research and Development	Research and Development Research and development expenses are incurred in support of internal development programs or as part of our joint development agreement with GLOBALFOUNDRIES and joint collaboration agreement with Silterra Malaysia Sdn. Bhd. (see Note 10). Research and development expenses include personnel-related costs (including stock-based compensation), circuit design costs, purchases of materials and laboratory supplies, fabrication and packaging of experimental integrated circuit products, depreciation of research and development related capital equipment and overhead, and are expensed as incurred.
Stock-based Compensation	Stock-based Compensation Stock-based compensation arrangements include stock option grants and restricted stock unit (RSU) awards under the Company’s equity incentive plans, as well as shares issued under the Company’s Employee Stock Purchase Plan (ESPP), through which employees may purchase the Company’s common stock at a discount to the market price. The Company measures its stock option grants made to employees based on the estimated fair value of the options as of the grant date using the Black-Scholes option-pricing model. Stock-based compensation expense is recognized over the requisite service period using the straight-line method. The Company has made an accounting policy election to account for forfeitures as they occur, rather than estimating expected forfeitures at the time of the grant. Stock-based compensation expense for options granted to non-employees as consideration for services received is measured on the date of performance at the fair value of the consideration received or the fair value of the equity instruments issued, using the Black-Scholes option-pricing model, whichever can be more reliably measured. Compensation expense for options granted to non-employees is periodically remeasured as the underlying options vest.
Income Taxes	Income Taxes The Company uses the liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are determined based on the differences between the financial reporting and the tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company must then assess the likelihood that the resulting deferred tax assets will be realized. A valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized. The Company recognizes benefits of uncertain tax positions if it is more likely than not that such positions will be sustained upon examination based solely on their technical merits, as the largest amount of benefit that is more likely than not to be realized upon the ultimate settlement. The Company’s policy is to recognize interest and penalties related to the underpayment of income taxes as a component of income tax expense or benefit. The Company does not have any unrecognized tax benefits.
Net Loss per Common Share	Net Loss per Common Share Basic net loss per common share is calculated by dividing the net loss by the weighted-average number of shares of common stock outstanding for the period less shares subject to repurchase, without consideration of potentially dilutive securities. Diluted net loss per common share is the same as basic net loss per common share since the effect of potentially dilutive securities is anti-dilutive.
Prior Period Reclassifications	Prior Period Reclassifications Certain amounts in the prior period have been reclassified to conform with current period presentation. There was no impact on total revenue or net loss for the prior period.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2018
Summary of Significant Accounting Policies
Schedule of accounts receivable net	Accounts receivable, net consisted of the following (in thousands): December 31, 2018 2017 Trade accounts receivable $ 7,297 $ 4,188 Unbilled accounts receivable 938 — Allowance for accounts receivable (713) (147) Accounts receivable, net $ 7,522 $ 4,041
Schedule of Revenue and Accounts Receivable for Each Significant Customer	Revenue Accounts Receivable, net Year Ended As of December 31, December 31, Customers 2018 2017 2018 2017 Customer A 13 % 16 % * * Customer B 11 % * * * Customer C 10 % * * 11 % Customer D * 15 % * * Customer E * * 23 % * Customer F * * 21 % * Customer G * * 11 % 15 % Customer H * * 11 % * Customer I * * * 10 % *
Schedule of Fair Value of Financial Assets Measured on Recurring Basis	The following tables sets forth the fair value of the Company’s financial assets measured at fair value on a recurring basis (in thousands): December 31, 2018 Level 1 Level 2 Level 3 Total Assets: Money market funds $ 23,478 $ — $ — $ 23,478 Total assets measured at fair value $ 23,478 $ — $ — $ 23,478 December 31, 2017 Level 1 Level 2 Level 3 Total Assets: Money market funds $ 13,369 $ — $ — $ 13,369 Total assets measured at fair value $ 13,369 $ — $ — $ 13,369
Schedule of estimated useful lives of the assets	Useful Lives Computer and network equipment 2 years Manufacturing equipment 2 – 7 years Furniture and fixtures 7 years Software 3 years
Schedule of impact of adopting Topic 606	The following table summarizes the impact of adopting Topic 606 on select balance sheet line items (in thousands): Balances without the adoption of December 31, 2018 As reported Adjustments Topic 606 Accounts receivable, net $ 7,522 $ (1,211) $ 6,311 Inventory 9,097 190 9,287 Total current assets 40,686 (1,021) 39,665 Total assets 45,045 (1,021) 44,024 Deferred income on shipments to distributors — 3,017 3,017 Total current liabilities 13,615 3,017 16,632 Total liabilities 20,124 3,017 23,141 Accumulated deficit (133,993) (4,038) (138,031) Total liabilities and stockholders’ equity 45,045 (1,021) 44,024 The following table summarizes the impact of adopting Topic 606 on select statement of operations line items (in thousands, except per share data): Results without the adoption of Year Ended December 31, 2018 As reported Adjustments Topic 606 Product sales $ 39,514 $ (2,915) $ 36,599 Licensing, royalty, and other revenue 9,903 (577) 9,326 Total revenue 49,417 (3,492) 45,925 Cost of sales 24,083 (754) 23,329 Gross profit 25,334 (2,738) 22,596 Loss from operations (17,321) (2,738) (20,059) Net loss and comprehensive loss (17,754) (2,738) (20,492) Net loss per common share, basic and diluted (1.08) (0.17) (1.25)

Revenue (Tables)

Revenue (Tables)	12 Months Ended
	Dec. 31, 2018
Revenue
Schedule of disaggregation of revenue	The following table presents the Company’s revenues disaggregated by sales channel, (in thousands): Year Ended December 31, 2018 Distributor $ 35,126 Non-distributor 14,291 Total revenue $ 49,417 The following table presents the Company’s revenues disaggregated by timing of recognition (in thousands): Year Ended December 31, 2018 Point in time $ 45,102 Over time 4,315 Total revenue $ 49,417 The following table presents the Company’s revenues disaggregated by type (in thousands): Year Ended December 31, 2018 Product sales $ 39,514 License fees 5,000 Royalties 588 Other revenue 4,315 Total revenue $ 49,417 The Company recognizes revenue in three primary geographic regions: North America; Europe, Middle East and Africa (EMEA); and Asia-Pacific and Japan (APJ). The following table presents the Company’s revenues disaggregated by the geographic region to which the product is delivered or licensee is located (in thousands): Year Ended December 31, 2018 North America $ 9,124 EMEA 11,175 APJ 29,118 Total revenue $ 49,417

Balance Sheet Components (Table

Balance Sheet Components (Tables)	12 Months Ended
	Dec. 31, 2018
Balance Sheet Components
Schedule of Inventory	Inventory consisted of the following (in thousands): December 31, 2018 2017 Raw materials $ 288 $ 682 Work-in-process 6,759 7,970 Finished goods 2,050 1,185 Total inventory $ 9,097 $ 9,837
Schedule of Property and equipment, net	Property and equipment, net consisted of the following (in thousands): December 31, 2018 2017 Manufacturing equipment $ 11,723 $ 10,465 Computer and network equipment 820 710 Furniture and fixtures 110 218 Software 680 455 Leasehold improvements 1,432 1,474 Total property and equipment, gross 14,765 13,322 Less: accumulated depreciation (10,479) (9,376) Total property and equipment, net $ 4,286 $ 3,946
Schedule of Accrued Liabilities	Accrued liabilities consisted of the following (in thousands): December 31, 2018 2017 Accrued payroll-related expenses $ 1,558 $ 1,331 Accrued joint development agreement expenses 661 749 Accrued inventory 1,678 897 Deferred rent 390 230 Accrued sales commissions payable to sales representatives 51 75 Other 663 466 Total accrued liabilities $ 5,001 $ 3,748

Commitments and Contingencies (

Commitments and Contingencies (Tables)	12 Months Ended
	Dec. 31, 2018
Commitments and Contingencies
Schedule of minimum rental commitments under operating leases	The following is a schedule of minimum rental commitments under the Company’s operating leases at December 31, 2018 (in thousands): Year Ending December 31, Amount 2019 $ 1,645 2020 1,701 2021 846 2022 47 2023 — Thereafter — Total minimum lease payments $ 4,239

Debt and Related Warrants (Tabl

Debt and Related Warrants (Tables)	12 Months Ended
	Dec. 31, 2018
Debt and Related Warrants
Summary of Debt	The carrying value of the Company’s Amended Credit Facility at December 31, 2018, was as follows (in thousands): Current Long-Term Portion Debt Total Credit Facility $ 6,000 $ 6,840 $ 12,840 Unamortized debt discounts (33) (341) (374) Net carrying value $ 5,967 $ 6,499 $ 12,466 The carrying value of the Company’s 2017 Credit Facility at December 31, 2017, was as follows (in thousands): Current Long-Term Portion Debt Total Credit Facility $ 4,000 $ 8,720 $ 12,720 Unamortized debt discounts (23) (563) (586) Net carrying value $ 3,977 $ 8,157 $ 12,134
Summary of Principal Repayments of Credit Facility	The table below includes the principal repayments due under the Amended Credit Facility as of December 31, 2018 (in thousands): Principal Repayment as of December 31, 2018 2019 $ 6,000 2020 6,840 2021 — 2022 — 2023 — Total principal repayments $ 12,840

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	12 Months Ended
	Dec. 31, 2018
Stockholders’ Equity
Summary of Common Stock Reserved for Future Issuance	December 31, 2018 2017 Options issued and outstanding 1,475,299 1,593,195 Shares available for future option grants 764,145 83,929 RSUs subject to future vesting 93,560 30,680 Common stock warrants 27,836 27,690 Total 2,360,840 1,735,494

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	12 Months Ended
	Dec. 31, 2018
Summary of Stock Option Activity	Options Outstanding Weighted- Weighted- Options and Average Average Awards Exercise Remaining Aggregate Available for Number of Price Per Contractual Intrinsic Grant Options Share Life (years) Value (In thousands) Balance—December 31, 2017 83,929 1,593,195 $ 8.88 6.6 $ 1,997 Immaterial prior period adjustment (1,026) 11,477 4.84 Authorized 1,084,516 — — RSUs granted (80,950) — — RSUs cancelled/forfeited 3,000 — — Options granted (434,665) 434,665 8.52 Options exercised — (448,411) 4.99 $ 1,915 Options cancelled/forfeited 109,341 (115,627) 8.68 Balance—December 31, 2018 764,145 1,475,299 $ 7.60 7.8 $ 284 Options exercisable—December 31, 2018 617,718 $ 6.79 6.4 $ 276
Schedule of Restricted Stock Unit Activity	RSUs Outstanding Weighted- Average Number of Grant Date Restricted Stock Fair Value Per Units Share Balance—December 31, 2017 30,680 $ 10.55 Granted 80,950 8.48 Vested (15,070) 13.41 Cancelled/forfeited (3,000) 8.10 Balance—December 31, 2018 93,560 $ 8.38
Summary of Stock-Based Compensation Expense	The Company recognized stock-based compensation expense from awards granted to employees and non-employees under its equity incentive plans and from its ESPP as follows, excluding amounts related to GLOBALFOUNDRIES, Inc. (GF) (in thousands): Year Ended December 31, 2018 2017 Research and development $ 492 $ 488 General and administrative 1,811 1,297 Sales and marketing 365 263 Total $ 2,668 $ 2,048
2016 Employee Stock Purchase Plan [Member]
Schedule of Fair Value Assumptions	Year Ended December 31, 2018 2017 Expected volatility 59.5 – 87.8 % 49.3 – 72.7 % Risk-free interest rate 0.94 – 2.11 % 0.49 – 1.02 % Expected term (in years) 0.5 – 1.0 0.5 – 1.0 Dividend yield — % — %
Employees [Member]
Schedule of Fair Value Assumptions	Year Ended December 31, 2018 2017 Expected volatility 51.9 – 56.6 % 46.7 – 52.0 % Risk-free interest rate 2.64 - 2.94 % 1.85 - 2.14 % Expected term (in years) 5.7 – 6.1 5.3 – 6.1 Dividend yield — % — %
Non-Employee [Member]
Schedule of Fair Value Assumptions	 Year Ended December 31, 2018 2017 Expected volatility 52.9 – 54.8 % 46.7 – 60.5 % Risk-free interest rate 2.68 - 2.97 % 2.09 – 2.44 % Expected term (in years) 8.0 – 8.8 7.2 – 9.6 Dividend yield — % — %

Geographic Information (Tables)

Geographic Information (Tables)	12 Months Ended
	Dec. 31, 2018
Geographic Information
Schedule of property and equipment by country	Property and equipment, net by country was as follows (in thousands): December 31, 2018 2017 United States $ 2,714 $ 2,594 Singapore 912 696 Taiwan 258 656 Other 402 — $ 4,286 $ 3,946
Schedule of revenue by country	Revenue by country was as follows (in thousands): Year Ended December 31, 2018 2017 Japan $ 10,254 $ 4,128 Germany 6,724 2,964 United States 6,746 4,759 China 5,083 2,588 Singapore 3,818 8,067 All other 16,792 13,430 Total revenue $ 49,417 $ 35,936

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2018
Income Taxes
Schedule of reconciliation of statutory federal income tax rate	Year Ended December 31, 2018 2017 Tax at statutory federal rate (21.0) % (34.0) % State taxes, net of federal benefit (1.7) (1.4) Stock-based compensation 1.5 (0.8) Nondeductible executive compensation 0.9 — Change in valuation allowance 20.6 (34.2) Federal tax rate change — 70.2 Other (0.3) 0.2 Provision for income taxes (0.0) % (0.0) %
Schedule of tax effects of temporary differences and carryforwards	The tax effects of temporary differences and carryforwards that give rise to significant portions of the deferred tax assets are as follows (in thousands): December 31, 2018 2017 Deferred tax assets: Net operating loss carryforwards $ 25,359 $ 22,586 Inventory 1,442 1,520 Accruals 760 401 Depreciation and amortization 88 60 Limitation on business interest 96 — Stock-based compensation 1,416 1,228 Gross deferred tax assets 29,161 25,795 Valuation allowance (29,073) (25,721) Deferred tax assets 88 74 Deferred tax liabilities: Prepaid expenses (88) (74) Deferred tax liabilities (88) (74) Net deferred tax assets $ — $ —

Net Loss Per Common Share (Tabl

Net Loss Per Common Share (Tables)	12 Months Ended
	Dec. 31, 2018
Net Loss Per Common Share
Computation of Basic and Diluted Net Loss Per Share	The following table sets forth the computation of basic and diluted net loss per share (in thousands, except share and per share amounts): Year Ended December 31, 2018 2017 Numerator: Net loss $ (17,754) $ (21,100) Denominator: Weighted-average common shares outstanding 16,413,733 12,640,094 Less: weighted-average unvested common shares subjected to repurchase (41,095) (155,110) Weighted-average common shares outstanding used to calculate net loss per common share, basic and diluted 16,372,638 12,484,984 Net loss per common share, basic and diluted $ (1.08) $ (1.69)
Schedule of Potentially Dilutive Securities Excluded from Diluted Net Loss Per Common Share	Year Ended December 31, 2018 2017 Options to purchase common stock 1,475,299 1,593,195 Restricted stock units 93,560 30,680 Common stock subject to repurchase — 96,153 Common stock warrants 27,836 27,690 Total 1,596,695 1,747,718

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Accounts receivable, net (Details) - USD ($)	Dec. 31, 2018	Dec. 31, 2017
Accounts receivable
Allowance for doubtful accounts	$ 0	$ 0
Allowance for product returns	144,000	147,000
Allowance for price concessions	569,000	0
Trade accounts receivable	7,297,000	4,188,000
Unbilled accounts receivable	938,000
Allowance for accounts receivable	(713,000)	(147,000)
Accounts receivable, net, Current, Total	$ 7,522,000	$ 4,041,000

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Schedule of Revenue and Accounts Receivable for Each Significant Customer (Details) - Customer Concentration Risk	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Revenue | Customer A
Concentration risk
Concentration risk percentage	13.00%	16.00%
Revenue | Customer B
Concentration risk
Concentration risk percentage	11.00%
Revenue | Customer B | Maximum
Concentration risk
Concentration risk percentage		10.00%
Revenue | Customer C
Concentration risk
Concentration risk percentage	10.00%
Revenue | Customer C | Maximum
Concentration risk
Concentration risk percentage		10.00%
Revenue | Customer D
Concentration risk
Concentration risk percentage		15.00%
Revenue | Customer D | Maximum
Concentration risk
Concentration risk percentage	10.00%
Revenue | Customer E | Maximum
Concentration risk
Concentration risk percentage	10.00%	10.00%
Revenue | Customer F | Maximum
Concentration risk
Concentration risk percentage	10.00%	10.00%
Revenue | Customer G | Maximum
Concentration risk
Concentration risk percentage	10.00%	10.00%
Revenue | Customer H | Maximum
Concentration risk
Concentration risk percentage	10.00%	10.00%
Revenue | Customer I | Maximum
Concentration risk
Concentration risk percentage	10.00%	10.00%
Accounts Receivable, net | Customer A | Maximum
Concentration risk
Concentration risk percentage	10.00%	10.00%
Accounts Receivable, net | Customer B | Maximum
Concentration risk
Concentration risk percentage	10.00%	10.00%
Accounts Receivable, net | Customer C
Concentration risk
Concentration risk percentage		11.00%
Accounts Receivable, net | Customer C | Maximum
Concentration risk
Concentration risk percentage	10.00%
Accounts Receivable, net | Customer D | Maximum
Concentration risk
Concentration risk percentage	10.00%	10.00%
Accounts Receivable, net | Customer E
Concentration risk
Concentration risk percentage	23.00%
Accounts Receivable, net | Customer E | Maximum
Concentration risk
Concentration risk percentage		10.00%
Accounts Receivable, net | Customer F
Concentration risk
Concentration risk percentage	21.00%
Accounts Receivable, net | Customer F | Maximum
Concentration risk
Concentration risk percentage		10.00%
Accounts Receivable, net | Customer G
Concentration risk
Concentration risk percentage	11.00%	15.00%
Accounts Receivable, net | Customer H
Concentration risk
Concentration risk percentage	11.00%
Accounts Receivable, net | Customer H | Maximum
Concentration risk
Concentration risk percentage		10.00%
Accounts Receivable, net | Customer I
Concentration risk
Concentration risk percentage		10.00%
Accounts Receivable, net | Customer I | Maximum
Concentration risk
Concentration risk percentage	10.00%

Summary of Significant Accoun_6

Summary of Significant Accounting Policies - Schedule of Fair Value of Financial Assets and Liabilities Measured on Recurring Basis (Details) - Recurring - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Fair Value
Total assets measured at fair value	$ 23,478	$ 13,369
Level 1 [Member]
Fair Value
Total assets measured at fair value	23,478	13,369
Money Market Funds [Member]
Fair Value
Money market funds	23,478	13,369
Money Market Funds [Member] | Level 1 [Member]
Fair Value
Money market funds	$ 23,478	$ 13,369

Summary of Significant Accoun_7

Summary of Significant Accounting Policies - Property and Equipment (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Impairment of Long-lived Assets
Impairment of long-lived assets	$ 0	$ 0
Computer and network equipment
Property and Equipment, Net
Useful Lives	2 years
Manufacturing equipment | Minimum
Property and Equipment, Net
Useful Lives	2 years
Manufacturing equipment | Maximum
Property and Equipment, Net
Useful Lives	7 years
Furniture and fixtures
Property and Equipment, Net
Useful Lives	7 years
Software
Property and Equipment, Net
Useful Lives	3 years

Summary of Significant Accoun_8

Summary of Significant Accounting Policies - Revenue Recognition - Condensed Balance Sheet (Details) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Summary of Significant Accounting Policies
Accumulated deficit	$ (133,993)	$ (117,539)
Current assets:
Accounts receivable, net	7,522	4,041
Inventory	9,097	9,837
Total current assets	40,686	27,418
Total assets	45,045	31,437
Current liabilities:
Deferred income on shipments to distributors		1,720
Total current liabilities	13,615	12,375
Total liabilities	20,124	20,553
Stockholders’ equity:
Accumulated deficit	(133,993)	(117,539)
Total liabilities and stockholders' equity	45,045	31,437
ASU 2014-09 | Balances without the adoption of Topic 606
Summary of Significant Accounting Policies
Accumulated deficit	(138,031)
Current assets:
Accounts receivable, net	6,311
Inventory	9,287
Total current assets	39,665
Total assets	44,024
Current liabilities:
Deferred income on shipments to distributors	3,017
Total current liabilities	16,632
Total liabilities	23,141
Stockholders’ equity:
Accumulated deficit	(138,031)
Total liabilities and stockholders' equity	44,024
ASU 2014-09 | Adjustments
Summary of Significant Accounting Policies
Accumulated deficit	(4,038)	1,300
Current assets:
Accounts receivable, net	(1,211)
Inventory	190
Total current assets	(1,021)
Total assets	(1,021)
Current liabilities:
Deferred income on shipments to distributors	3,017
Total current liabilities	3,017
Total liabilities	3,017
Stockholders’ equity:
Accumulated deficit	(4,038)	$ 1,300
Total liabilities and stockholders' equity	$ (1,021)

Summary of Significant Accoun_9

Summary of Significant Accounting Policies - Revenue Recognition - Condensed Statement of Operations (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Summary of Significant Accounting Policies
Total revenue	$ 49,417	$ 35,936
Total cost of sales	24,083	14,451
Gross profit	25,334	21,485
Loss from operations	(17,321)	(20,208)
Net loss and comprehensive loss	$ (17,754)	$ (21,100)
Net loss per common share, basic and diluted	$ (1.08)	$ (1.69)
Product sales
Summary of Significant Accounting Policies
Total revenue	$ 39,514
Licensing, royalty and other revenue
Summary of Significant Accounting Policies
Total revenue	9,903
ASU 2014-09 | Balances without the adoption of Topic 606
Summary of Significant Accounting Policies
Total revenue	45,925
Total cost of sales	23,329
Gross profit	22,596
Loss from operations	(20,059)
Net loss and comprehensive loss	$ (20,492)
Net loss per common share, basic and diluted	$ (1.25)
ASU 2014-09 | Adjustments
Summary of Significant Accounting Policies
Total revenue	$ (3,492)
Total cost of sales	(754)
Gross profit	(2,738)
Loss from operations	(2,738)
Net loss and comprehensive loss	$ (2,738)
Net loss per common share, basic and diluted	$ (0.17)
ASU 2014-09 | Product sales | Balances without the adoption of Topic 606
Summary of Significant Accounting Policies
Total revenue	$ 36,599
ASU 2014-09 | Product sales | Adjustments
Summary of Significant Accounting Policies
Total revenue	(2,915)
ASU 2014-09 | Licensing, royalty and other revenue | Balances without the adoption of Topic 606
Summary of Significant Accounting Policies
Total revenue	9,326
ASU 2014-09 | Licensing, royalty and other revenue | Adjustments
Summary of Significant Accounting Policies
Total revenue	$ (577)

Summary of Significant Accou_10

Summary of Significant Accounting Policies - Recently issued pronouncements (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Jan. 01, 2019
Recently Issued Pronouncement
Original expected duration	true
Underlying contract	true
ASU 2016-02 | Minimum
Recently Issued Pronouncement
Right-of-use assets		$ 3.6
Operating leases liabilities		3.6
ASU 2016-02 | Maximum
Recently Issued Pronouncement
Right-of-use assets		4
Operating leases liabilities		$ 4

Revenue - Disaggregated by Sale

Revenue - Disaggregated by Sales Channel (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Disaggregation of Revenue
Revenue	$ 49,417	$ 35,936
Distributor
Disaggregation of Revenue
Revenue	35,126
Non-distributor
Disaggregation of Revenue
Revenue	$ 14,291

Revenue - Disaggregated by Timi

Revenue - Disaggregated by Timing of Recognition (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Disaggregation of Revenue
Revenue	$ 49,417	$ 35,936
Point in time
Disaggregation of Revenue
Revenue	45,102
Over time
Disaggregation of Revenue
Revenue	$ 4,315

Revenue - Disaggregated by Type

Revenue - Disaggregated by Type (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Disaggregation of Revenue
Revenue	$ 49,417	$ 35,936
Product sales
Disaggregation of Revenue
Revenue	39,514
License fees
Disaggregation of Revenue
Revenue	5,000
Royalties
Disaggregation of Revenue
Revenue	588
Other revenue
Disaggregation of Revenue
Revenue	$ 4,315

Revenue - Disaggregated by Geog

Revenue - Disaggregated by Geographic Region (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2018USD ($)region	Dec. 31, 2017USD ($)
Disaggregation of Revenue
Number of primary geographic regions | region	3
Revenue	$ 49,417	$ 35,936
North America
Disaggregation of Revenue
Revenue	9,124
EMEA
Disaggregation of Revenue
Revenue	11,175
APJ
Disaggregation of Revenue
Revenue	$ 29,118

Balance Sheet Components - Sche

Balance Sheet Components - Schedule of Inventory (Details) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Inventory
Raw materials	$ 288	$ 682
Work-in-process	6,759	7,970
Finished goods	2,050	1,185
Total inventory	$ 9,097	$ 9,837

Balance Sheet Components - Prop

Balance Sheet Components - Property and Equipment Net (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Property and Equipment, Net
Total property and equipment, gross	$ 14,765	$ 13,322
Less: accumulated depreciation	(10,479)	(9,376)
Total property and equipment, net	4,286	3,946
Depreciation and amortization expense	1,500	1,200
Manufacturing equipment
Property and Equipment, Net
Total property and equipment, gross	11,723	10,465
Computer and network equipment
Property and Equipment, Net
Total property and equipment, gross	820	710
Furniture and fixtures
Property and Equipment, Net
Total property and equipment, gross	110	218
Software
Property and Equipment, Net
Total property and equipment, gross	680	455
Leasehold improvements
Property and Equipment, Net
Total property and equipment, gross	$ 1,432	$ 1,474

Balance Sheet Components - Sc_2

Balance Sheet Components - Schedule of Accrued Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Accrued liabilities
Accrued payroll-related expenses	$ 1,558	$ 1,331
Accrued joint development agreement expenses	661	749
Accrued inventory	1,678	897
Deferred rent	390	230
Accrued sales commissions payable to sales representatives	51	75
Other	663	466
Total accrued liabilities	$ 5,001	$ 3,748

Commitments and Contingencies_2

Commitments and Contingencies (Details)	1 Months Ended	12 Months Ended
	Apr. 30, 2018USD ($)	Dec. 31, 2018USD ($)	Dec. 31, 2017USD ($)ft²
Minimum rental commitments
2019		$ 1,645,000
2020		1,701,000
2021		846,000
2022		47,000
Total minimum lease payments		4,239,000
Total rent expense		$ 1,600,000	$ 1,400,000
Arizona manufacturing facility | Freescale [Member]
Minimum rental commitments
Period to cancel lease upon notice		24 months
Period to cancel lease upon notice		24 months
Previous Headquarters
Minimum rental commitments
Area of operating lease (in sq feet) | ft²			27,974
Write off of unamortized deferred rent	$ 18,000
Lease termination fee	$ 43,000

Debt and Related Warrants - Cre

Debt and Related Warrants - Credit Facility (Details)	Jul. 06, 2018payment	May 04, 2017USD ($)payment	May 31, 2017USD ($)	Apr. 30, 2017USD ($)	Dec. 31, 2018USD ($)	Dec. 31, 2017USD ($)	Jun. 30, 2015USD ($)
Debt
Gain on extinguishment of debt						$ (246,000)
Revolving Loan [Member]
Debt
Loan agreement amount							$ 4,000,000
Repayment of credit facility				$ 1,100,000
Unamortized Debt Issuance Expense				$ 10,000
Term Loan 2015 Credit Facility
Debt
Loan agreement amount							$ 8,000,000
Repayment of credit facility			$ 6,200,000
Payments of Debt Extinguishment Costs			61,000
Unamortized Debt Issuance Expense			$ 175,000
SVB Credit Facility [Member]
Debt
Loan agreement amount		$ 12,000,000
Interest rate					7.77%
Reimbursement of principal payments					$ 1,000,000
End-of-term fee (as a percent)	7.00%	6.00%
SVB Credit Facility [Member] | Minimum
Debt
Number of interest and principal payments | payment	24	24
SVB Credit Facility [Member] | Maximum
Debt
Number of interest and principal payments | payment	36	36
SVB Credit Facility [Member] | Prime Rate [Member]
Debt
Interest rate, negative basis spread percentage	0.75%	0.75%
Interest rate					4.75%

Debt and Related Warrants - Car

Debt and Related Warrants - Carrying Value (Details) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Debt
Net carrying value of debt, Current Portion	$ 5,977	$ 3,987
Net carrying value of debt, Long-term debt	6,509	8,178
SVB Credit Facility [Member]
Debt
Debt, Current Portion	6,000	4,000
Less: Debt issuance costs, Current Portion	(33)	(23)
Net carrying value of debt, Current Portion	5,967	3,977
Debt, including end of term fee, Long-term debt	6,840	8,720
Less: Unamortized debt discounts, Long-term debt	(341)	(563)
Net carrying value of debt, Long-term debt	6,499	8,157
Total principal repayments	12,840	12,720
Less: Discount attributable to warrants, end of term fee and debt issuance costs, Total	(374)	(586)
Net carrying value of debt, Total	$ 12,466	$ 12,134

Debt and Related Warrants - Sum

Debt and Related Warrants - Summary of Principal Repayments of 2017 Credit Facility (Details) - SVB Credit Facility [Member] - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Debt
2019	$ 6,000
2020	6,840
Total principal repayments	$ 12,840	$ 12,720

Debt and Related Warrants - War

Debt and Related Warrants - Warrants - Additional Information (Details) - USD ($)	1 Months Ended
	May 31, 2017	Apr. 30, 2017	Jun. 30, 2015
Term Loan 2015 Credit Facility
Warrants
Loan agreement amount			$ 8,000,000
Repayment of credit facility	$ 6,200,000
Unamortized debt discount	175,000
Prepayment penalty	$ 61,000
Revolving Loan [Member]
Warrants
Loan agreement amount			$ 4,000,000
Repayment of credit facility		$ 1,100,000
Unamortized debt discount		$ 10,000

Debt and Related Warrants - Cap

Debt and Related Warrants - Capital Lease Obligations (Details) - USD ($)	Dec. 31, 2018	Dec. 31, 2017
Debt and Related Warrants
Capital lease obligations future minimum lease payments	$ 20,000	$ 31,000
Property and equipment under capital leases	31,000	31,000
Capital lease obligations accumulated depreciation and amortization	13,000	$ 2,000
Future minimum rental commitments
2019	10,000
2020	$ 10,000

Stockholders' Equity - (Details

Stockholders' Equity - (Details) - USD ($) $ / shares in Units, $ in Millions	1 Months Ended	12 Months Ended
	Feb. 28, 2018	Dec. 31, 2017	Dec. 31, 2018
Common stock reserved
Dividends on common stock		$ 0
Reserved shares of common stock for future issuance		1,735,494	2,360,840
Sale of common stock
Number of shares sold	3,772,447
Offering price	$ 7
Proceeds from stock offering, net of offering costs	$ 24.5
Offering costs	$ 1.9
Common Stock Warrants
Common stock reserved
Reserved shares of common stock for future issuance		27,690	27,836
Options Issued and Outstanding [Member]
Common stock reserved
Reserved shares of common stock for future issuance		1,593,195	1,475,299
Shares Available for Future Option Grants [Member]
Common stock reserved
Reserved shares of common stock for future issuance		83,929	764,145
RSUs Subject to Future Vesting
Common stock reserved
Reserved shares of common stock for future issuance		30,680	93,560

Stockholders_ Equity - Warrants

Stockholders’ Equity - Warrants (Details) - USD ($)	Jul. 06, 2018	Jun. 30, 2015	Dec. 31, 2010
Warrants to Purchase Series A Redeemable Convertible Preferred Stock [Member] | SVB Credit Facility [Member]
Warrants
Number of shares the warrant can be converted to			9,229
Warrant exercise price			$ 26
Warrants to Purchase Series B Redeemable Convertible Preferred Stock [Member] | 2015 Credit Facility [Member]
Warrants
Number of shares the warrant can be converted to		18,461
Warrant exercise price		$ 26
Warrant exercise expiration period		10 years
Warrants to Purchase Series B Redeemable Convertible Preferred Stock [Member] | SVB Credit Facility [Member]
Warrants
Number of shares the warrant can be converted to	9,375
Warrant exercise price	$ 8.91
Fair Value Of Warrants	$ 43,000
Warrant exercise expiration period	5 years

Stock-Based Compensation - Summ

Stock-Based Compensation - Summary of Options and Awards Activity (Details) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Stock-based compensation
Options and Awards Available for Grant, Outstanding, Beginning balance	83,929
Options and Awards Available for Grant, Immaterial prior period adjustment	(1,026)
Options and Awards Available for Grant, Options authorized	1,084,516
Options and Awards Available for Grant, Options granted	(434,665)
Options Available for Grant, Options exercised	0
Options and Awards Available for Grant, Options cancelled/forfeited	109,341
Options and Awards Available for Grant, Outstanding, Ending balance	764,145	83,929
Number of Options, Outstanding, Beginning balance	1,593,195
Number of Options, Immaterial prior period adjustment	11,477
Number of Options, Options granted	434,665
Number of Options, Options exercised	(448,411)
Number of Options, Options cancelled/forfeited	(115,627)
Number of Options, Outstanding, Ending balance	1,475,299	1,593,195
Number of Options, exercisable	617,718
Weighted - Average Exercise Price Per Share, Options outstanding, Beginning balance	$ 8.88
Weighted - Average Exercise Price Per Share, Immaterial prior period adjustment	4.84
Weighted - Average Exercise Price Per Share, Options granted	8.52
Weighted - Average Exercise Price Per Share, Options exercised	4.99
Weighted - Average Exercise Price Per Share, Options cancelled/forfeited	8.68
Weighted - Average Exercise Price Per Share, Options outstanding, Ending balance	7.60	$ 8.88
Weighted - Average Exercise Price Per Share, Options exercisable	$ 6.79
Weighted - Average Remaining Contractual Life, Options outstanding	7 years 9 months 18 days	6 years 7 months 6 days
Weighted - Average Remaining Contractual Life, Options exercisable	6 years 4 months 24 days
Aggregate Intrinsic Value, Options outstanding	$ 284	$ 1,997,000
Aggregate Intrinsic Value, Options exercised	1,915
Aggregate Intrinsic Value, Options exercisable	$ 276
RSU
Stock-based compensation
Options and Awards Available for Grant, RSUs granted	(80,950)
Options Available for Grant, RSUs cancelled/forfeited	3,000

Stock-Based Compensation - Addi

Stock-Based Compensation - Additional Information (Details)	Oct. 07, 2016shares	Sep. 20, 2016itemshares	Feb. 28, 2018USD ($)$ / sharesshares	Dec. 31, 2018USD ($)$ / sharesshares	Dec. 31, 2017USD ($)$ / sharesshares	Jan. 31, 2018$ / shares
Share-based Compensation
Shares available for future issuance (in shares)				764,145	83,929
Value of share issued | $				$ 2,503,000
Number of stock options granted (in shares)				434,665
Options remained outstanding				1,475,299	1,593,195
Weighted-average grant date fair value of options granted | $ / shares				$ 4.45	$ 6.48
Total grant date fair value of options vested | $				$ 1,900,000	$ 1,500,000
Unrecognized compensation expense related to unvested options | $				$ 4,800,000
Unrecognized compensation expense, weighted-average period expected to be recognized				2 years 8 months 12 days
Number of vested and unvested stock option award modified			400,000
Weighted-average exercise price (per share) | $ / shares				$ 7.60	$ 8.88
Stock-based compensation expense | $				$ 2,668,000	$ 2,048,000
Immediate vesting
Share-based Compensation
Incremental modification value | $			$ 63,000
Remaining vesting
Share-based Compensation
Incremental modification value | $			$ 537,000
Former Chief Executive Officer | Accelerated Vesting Due To Separation Agreement
Share-based Compensation
Stock-based compensation expense | $					310,000
Chief Executive Officer
Share-based Compensation
Weighted-average exercise price (per share) | $ / shares			$ 7.64			$ 16.25
Incremental modification value | $			$ 600,000
Employees [Member]
Share-based Compensation
Stock-based compensation expense | $				$ 2,600,000	$ 2,000,000
Non-Employee [Member]
Share-based Compensation
Number of stock options granted (in shares)				8,400	16,800
Options remained outstanding				43,865	37,872
Weighted-average grant date fair value of options granted | $ / shares				$ 8.91	$ 13.74
Weighted-average exercise price (per share) | $ / shares				$ 9.25	$ 9.16
Stock-based compensation expense | $				$ 31,000	$ 69,000
2016 Employee Incentive Plan [Member]
Share-based Compensation
Maximum number of common stock shares may be issued under the plan	500,000
Annual increases in the number of shares available for issuance, percentage of outstanding capital stock	3.00%
2008 Equity Incentive Plan [Member]
Share-based Compensation
Vesting period				4 years
Exercise period				10 years
Options remained outstanding				407,780
2008 Equity Incentive Plan [Member] | Incentive Stock Options | Minimum
Share-based Compensation
Percentage of exercise price of fair market value of stock at the date of grant				100.00%
2008 Equity Incentive Plan [Member] | Incentive Stock Options | Maximum
Share-based Compensation
Percentage of exercise price of fair market value of stock at the date of grant				110.00%
2016 Employee Stock Purchase Plan [Member]
Share-based Compensation
Maximum number of common stock shares may be issued under the plan		96,153
Annual increases in the number of shares available for issuance, percentage of outstanding capital stock		1.00%
Increase in number of shares available for grant				128,172	124,981
Number of purchase periods | item		2
Length of time of purchase period (in months)		6 months
Shares available for future issuance (in shares)				269,389
Number of shares issued (in shares)				42,327	37,590
Value of share issued | $				$ 266,000	$ 256,000

Stock-Based Compensation - Rest

Stock-Based Compensation - Restricted Stock Units (Details)	12 Months Ended
	Dec. 31, 2018USD ($)$ / sharesshares
Weighted Average Exercise Price Per Share
Unrecognized compensation expense, weighted-average period expected to be recognized	2 years 8 months 12 days
2016 Employee Incentive Plan [Member] | RSU
Number of Restricted Stock Units
Balance, beginning of period | shares	30,680
Granted | shares	80,950
Vested | shares	(15,070)
Cancelled/forfeited | shares	(3,000)
Balance, end of period | shares	93,560
Weighted Average Exercise Price Per Share
Balance, beginning of period (price per share) | $ / shares	$ 10.55
Granted (price per share) | $ / shares	8.48
Vested (price per share) | $ / shares	13.41
Cancelled/forfeited (price per share) | $ / shares	8.10
Balance, end of period (price per share) | $ / shares	$ 8.38
Unrecognized stock-based compensation expense | $	$ 594,000
Unrecognized compensation expense, weighted-average period expected to be recognized	2 years 8 months 12 days

Stock-Based Compensation - Su_2

Stock-Based Compensation - Summary of Stock-Based Compensation Expense (Details) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Share-based compensation expense
Stock-based compensation expense	$ 2,668,000	$ 2,048,000
Unrecognized compensation expense, weighted-average period expected to be recognized	2 years 8 months 12 days
Research and Development [Member]
Share-based compensation expense
Stock-based compensation expense	$ 492,000	488,000
General and Administrative [Member]
Share-based compensation expense
Stock-based compensation expense	1,811,000	1,297,000
Sales and Marketing [Member]
Share-based compensation expense
Stock-based compensation expense	365,000	263,000
Non-Employee [Member]
Share-based compensation expense
Stock-based compensation expense	$ 31,000	$ 69,000

Stock-Based Compensation - Sche

Stock-Based Compensation - Schedule of Fair Value of Employee Stock Options (Details)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Employees [Member] | Options to Purchase Common Stock
Share-based Compensation
Expected volatility, Minimum	51.90%	46.70%
Expected volatility, Maximum	56.60%	52.00%
Risk-free interest rate, Minimum	2.64%	1.85%
Risk-free interest rate, Maximum	2.94%	2.14%
Dividend yield	0.00%	0.00%
Employees [Member] | Minimum | Options to Purchase Common Stock
Share-based Compensation
Expected term (in years)	5 years 8 months 12 days	5 years 3 months 18 days
Employees [Member] | Maximum | Options to Purchase Common Stock
Share-based Compensation
Expected term (in years)	6 years 1 month 6 days	6 years 1 month 6 days
Non-Employee [Member] | Options to Purchase Common Stock
Share-based Compensation
Expected volatility, Minimum	52.90%	46.70%
Expected volatility, Maximum	54.80%	60.50%
Risk-free interest rate, Minimum	2.68%	2.09%
Risk-free interest rate, Maximum	2.97%	2.44%
Non-Employee [Member] | Minimum | Options to Purchase Common Stock
Share-based Compensation
Expected term (in years)	8 years	7 years 2 months 12 days
Non-Employee [Member] | Maximum | Options to Purchase Common Stock
Share-based Compensation
Expected term (in years)	8 years 9 months 18 days	9 years 7 months 6 days
2016 Employee Stock Purchase Plan [Member]
Share-based Compensation
Expected volatility, Minimum	59.50%	49.30%
Expected volatility, Maximum	87.80%	72.70%
Risk-free interest rate, Minimum	0.94%	0.49%
Risk-free interest rate, Maximum	2.11%	1.02%
2016 Employee Stock Purchase Plan [Member] | Minimum
Share-based Compensation
Expected term (in years)	6 months	6 months
2016 Employee Stock Purchase Plan [Member] | Maximum
Share-based Compensation
Expected term (in years)	1 year	1 year

Significant Agreements (Details

Significant Agreements (Details) - USD ($) $ / shares in Units, $ in Thousands	Aug. 21, 2016	Oct. 21, 2014	Oct. 17, 2014	Sep. 30, 2018	Feb. 28, 2018	Dec. 31, 2018	Dec. 31, 2017
Joint development agreement
Research and development expense						$ 23,637	$ 25,437
Number of shares sold					3,772,447
Non-cash compensation expense (income)						$ 753	1,472
Common Stock [Member]
Joint development agreement
Number of shares sold						3,772,447
Joint Development Agreement [Member] | Global Foundries, Inc. [Member]
Joint development agreement
Agreement Term			4 years
Period of possession of exclusive right to manufacture after qualification of device			3 years
Period of possession of exclusive right to manufacture after completion of device development work			4 years
Research and development expense						$ 5,800	5,200
Milestone revenue						1,000	1,600
Joint Development Agreement [Member] | Global Foundries, Inc. [Member] | Common Stock [Member]
Joint development agreement
Number of shares sold		461,538
Shares sold, price per share		$ 0.00026
Number of shares of common stock, vested	211,538
Joint Development Agreement [Member] | Global Foundries, Inc. [Member] | Research and Development [Member]
Joint development agreement
Non-cash compensation expense (income)						800	$ 1,500
Joint Development Agreement [Member] | Global Foundries, Inc. [Member] | Series B Redeemable Convertible Preferred Stock [Member]
Joint development agreement
Number of shares sold		192,307
Shares sold, price per share		$ 26
Collaborative Agreement | Silterra
Joint development agreement
Non-recurring engineering cost obligation				$ 1,000
JCA costs						$ 800

Geographic Information (Details

Geographic Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Geographic Information
Property and equipment, net	$ 4,286	$ 3,946
Revenue	49,417	35,936
Japan
Geographic Information
Revenue	10,254	4,128
Germany
Geographic Information
Revenue	6,724	2,964
United States
Geographic Information
Property and equipment, net	2,714	2,594
Revenue	6,746	4,759
China
Geographic Information
Revenue	5,083	2,588
Singapore
Geographic Information
Property and equipment, net	912	696
Revenue	3,818	8,067
Taiwan
Geographic Information
Property and equipment, net	258	656
All other
Geographic Information
Property and equipment, net	402
Revenue	$ 16,792	$ 13,430

Income Taxes - Reconciliation E

Income Taxes - Reconciliation Effective Tax Rate (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Income Taxes
Provision for income taxes	$ 0	$ 0
Reconciliation of statutory federal income tax
Tax at statutory federal rate	(21.00%)	(34.00%)
State taxes, net of federal benefit	(1.70%)	(1.40%)
Stock-based compensation	1.50%	(0.80%)
Nondeductible executive compensation	0.90%
Change in valuation allowance	20.60%	(34.20%)
Federal tax rate change		70.20%
Other	(0.30%)	0.20%
Provision for income taxes	0.00%	0.00%

Income Taxes - Deferred tax ass

Income Taxes - Deferred tax assets (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Deferred tax assets:
Net operating loss carryforwards	$ 25,359	$ 22,586
Inventory	1,442	1,520
Accruals	760	401
Depreciation and amortization	88	60
Limitation on business interest	96
Stock-based compensation	1,416	1,228
Gross deferred tax assets	29,161	25,795
Valuation allowance	(29,073)	(25,721)	$ (32,800)
Deferred tax assets	88	74
Deferred tax liabilities:
Prepaid expenses	(88)	(74)
Deferred tax liabilities	(88)	(74)
Increase in valuation allowance	$ 3,400
Decrease in valuation allowance		$ 7,100
Tax at statutory federal rate	21.00%	34.00%

Income Taxes - Net operating lo

Income Taxes - Net operating loss carryforwards and Tax Act (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Net operating loss carryforwards
Tax at statutory federal rate	21.00%	34.00%
Federal
Net operating loss carryforwards
Net operating loss carryforwards	$ 112.3
Net operating loss carryforwards, which will expire if not utilized	99.7
Net operating loss carryforwards, which will carryover indefinitely	12.6
State
Net operating loss carryforwards
Net operating loss carryforwards	44.3
Net operating loss carryforwards, which will expire if not utilized	43.5
Net operating loss carryforwards, which will carryover indefinitely	$ 0.8

Net Loss Per Common Share - Com

Net Loss Per Common Share - Computation of Basic and Diluted Net Loss Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Numerator:
Net loss	$ (17,754)	$ (21,100)
Denominator:
Weighted-average common shares outstanding	16,413,733	12,640,094
Less: weighted-average unvested common shares subjected to repurchase	(41,095)	(155,110)
Weighted-average common shares outstanding used to calculate net loss per common share, basic and diluted	16,372,638	12,484,984
Net loss per common share, basic and diluted	$ (1.08)	$ (1.69)

Net Loss Per Common Share - Sch

Net Loss Per Common Share - Schedule of Potentially Dilutive Securities Excluded from Diluted Net Loss Per Common Share (Details) - shares	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Antidilutive Securities
Potentially dilutive securities excluded from diluted net loss per common share	1,596,695	1,747,718
Options to Purchase Common Stock
Antidilutive Securities
Potentially dilutive securities excluded from diluted net loss per common share	1,475,299	1,593,195
RSU
Antidilutive Securities
Potentially dilutive securities excluded from diluted net loss per common share	93,560	30,680
Common Stock Subject to Repurchase
Antidilutive Securities
Potentially dilutive securities excluded from diluted net loss per common share		96,153
Common Stock Warrants
Antidilutive Securities
Potentially dilutive securities excluded from diluted net loss per common share	27,836	27,690